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ABSTRACT 
 
HOW THE E. COLI HSP70 MOLECULAR CHAPERONE, DNAK, BINDS A CLIENT 
PROTEIN 
 
SEPTEMBER 2017 
JOSEPH M. TILITSKY 
B.Sc., UNIVERSITY OF VIRGINIA 
 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Lila M. Gierasch 
 
Protein folding is essential for all cellular life. While some proteins are able to reach their 
folded state reliably using nothing but their amino acid sequence, a great number of 
essential proteins are unable to do so without the aid of molecular chaperones. One 
family of molecular chaperone, the Hsp70 family, is found in virtually all cell types and 
across all domains of life. Certain to the function of Hsp70s are how they bind their client 
proteins. Substantial effort has been expended to study how Hsp70s work on model 
peptides as a substrate mimic, but relatively little work has been performed using full-
length protein substrates. This work examines how the E. coli Hsp70, DnaK, binds a full-
length unfolded client protein, the pro-form of E. coli alkaline phosphatase, or proPhoA. I 
use a combination of biophysical techniques to under how DnaK binds proPhoA with 
regards to affinity, stoichiometry, and binding site selection. I find that DnaK binds each 
  
 
vii 
of the potential binding sites within proPhoA with roughly equal affinity. In addition, 
DnaK for a complex with proPhoA with a 1:1 stoichiometry and is selective for a single 
binding site on proPhoA.  
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CHAPTER 1 
 
INTRODUCTION 
 
Proteins serve as both the engine and transmission that power the vehicle that is the cell. 
In order for them to perform their myriad functions correctly, proteins frequently need to 
fold into distinct structures. Molecular chaperones oversee this process and provide 
essential quality control for this complicated task. In this chapter I will discuss what is 
know about how molecular chaperones perform their vital functions with particular 
emphasis on how one class of chaperone, the Hsp70 family, recognizes client proteins. 
Sections of this chapter were co-authored with my advisor and lab mates Eugenia Clerico 
and Wenli Meng and published in the review “How hsp70 molecular machines interact 
with their substrates to mediate diverse physiological functions” Journal of Molecular 
Biology April 2015.  
 
1.1 Hsp70s as hubs of proteostasis 
Hsp70 molecular chaperones have a deceptively simple mechanism of action: They bind 
via their substrate-binding domain (SBD) to short polypeptide sequences with recognition 
motifs that are not stringently defined but can be identified by common features. The 
affinity of Hsp70s for their substrates is modulated allosterically by nucleotide binding to 
their N-terminal actin-like nucleotide-binding domain (NBD), with ATP binding causing 
a reduction in affinity and ADP binding leading to high substrate affinity. The past few 
years have provided deep insights into the structural basis of Hsp70 allostery, much of it 
based on the E. coli Hsp70 family member, DnaK (Mayer, 2013; Zuiderweg et al., 2013). 
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In the ADP-bound state of DnaK, the NBD and the SBD are largely independent, 
behaving like the separate domains connected by a flexible linker (Bertelsen et al., 2009). 
Upon ATP binding, the two domains are intimately docked with a conserved 
hydrophobic sequence in the interdomain linker forming a key part of the packing 
interface between domains (Kityk et al., 2012; Qi et al., 2013; Swain et al., 2007). 
Substrate binding to the ADP-bound DnaK is characterized by slow on-off kinetics. In 
the presence of ATP, substrate binding stimulates the ATP hydrolysis rate of the NBD, 
and the on and off rates for substrate binding are accelerated, leading to lower overall 
affinity and consequently favoring substrate release (De Los Rios and Barducci, 2014). 
Atomic structures are now available for both ADP- (Bertelsen et al., 2009) and ATP-
bound DnaK, (Kityk et al., 2012; Qi et al., 2013) and an activated state of DnaK with 
both ATP and a substrate peptide bound was recently described, in which the 
hydrophobic linker sequence is associated with the NBD but the domains are not fully 
docked on each other (Lai et al., 2017; Zhuravleva et al., 2012). From the reference frame 
of the SBD, ATP binding in the NBD activates an allosteric network culminating in two 
‘arch’ residues (Mayer et al., 2000) changing position to allow substrate binding in the 
canonical peptide binding groove (Zhuravleva and Gierasch, 2015). In physiological 
contexts, the allosteric cycle of Hsp70s is modulated by co-chaperones including 
nucleotide exchange factors (NEFs), which stimulate exchange of ADP for ATP, and J 
proteins, which both facilitate substrate delivery to Hsp70s and catalyze ATP hydrolysis 
(Zuiderweg et al., 2013). The impact of J proteins in modulating Hsp70-substrate 
interactions is of great importance to the interplay of this chaperone system with its 
clients and will be discussed in greater detail in a later section. While the allosteric 
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mechanism of Hsp70s has been elucidated to a great extent, our understanding of the 
impact of Hsp70 chaperone actions on their substrates remains shallow despite the fact 
that this is the essence of Hsp70 physiological functions.  
 
Hsp70s facilitate a stunning array of diverse functions. Their ability to do so is a 
consequence of their intrinsic allosteric mechanism coupled with their ability to 
cooperate with upstream and downstream chaperone partners. For example, all Hsp70s 
partner with J-protein family members, which are highly diverse, specialized, and 
spatially restricted (Kampinga and Craig, 2010). Hsp70 actions include optimization of 
folding and minimization of aggregation, both early in the biogenesis of proteins and 
upon stress-induced unfolding; shepherding proteins across membranes in translocation 
processes that require substrates to remain unfolded; promoting disassembly of large 
protein complexes; working with partner chaperones to mediate disaggregation reactions; 
and hand-off of substrates to downstream chaperones in folding and assembly reactions. 
When proteins fail to acquire the proper structure for downstream steps, Hsp70s work 
with their co-chaperones and partner chaperones to provide a quality control mechanism 
that includes shunting non-competent proteins to degradation (Kim et al., 2013; Lanneau 
et al., 2010). 
 
Despite this physiological diversity, all Hsp70 functions share a reliance on their ability 
to bind and release short unstructured sequences in their substrates. Importantly, the 
extent to which this binding reaction remodels the substrate and alters its conformational 
ensemble is critical to the biological outcome. Questions that must be addressed to get to 
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the heart of the action of Hsp70s on their substrates include: what is the nature of the 
recognition of substrates, including sequence and conformational requirements in the 
substrate for binding, whether and how the binding and release by the chaperone remodel 
the substrate, whether there is a direct mechanical action of Hsp70s on substrates, 
how/whether subsequent processes involving the substrate (folding, translocation, etc.) 
are favored because of the action of the Hsp70, and how hand-off to downstream 
chaperones is facilitated by Hsp70 action.  
 
1.2 The basis of substrate recognition by Hsp70s: peptides 
It was discovered early on that Hsp70s bind a variety of peptides seven residues in length, 
and that these fragments, like protein substrates, activate the ATPase activity of the 
chaperone (Flynn et al., 1989; Gragerov and Gottesman, 1994; Gragerov et al., 1994). 
From that point on, there has been heavy reliance on peptide models to understand the 
basis of substrate recognition by Hsp70s. Peptide library and phage display studies with 
several Hsp70s showed a preference for hydrophobic residues and positive charge, but 
without any clear binding motif (Blond-Elguindi et al., 1993; Flynn et al., 1989; Fourie et 
al., 1994; Rudiger et al., 1997; Van Durme et al., 2009). Nonetheless, enough sequence 
bias has been extracted from these studies to develop predictive algorithms to identify 
potential Hsp70 binding sites (Blond-Elguindi et al., 1993; Flynn et al., 1989; Fourie et 
al., 1994; Rudiger et al., 1997; Srinivasan et al., 2012; Van Durme et al., 2009). From the 
earliest phage display work, it appeared that sequence preferences may differ from one 
Hsp70 to another, (Blond-Elguindi et al., 1993; Flynn et al., 1989; Fourie et al., 1994) but 
the overlap in binding capacity is high and it remains an open question to what extent 
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Hsp70s have binding sequence biases (Marcinowski et al., 2011). Current thinking is that 
the J-protein partners of Hsp70s provide most of the physiological substrate specificity, 
(Kampinga and Craig, 2010; Vembar et al., 2010) which is also consistent with the 
greater number of different J-proteins than Hsp70s in a given cellular compartment, and 
particularly the larger number in eukaryotes relative to prokaryotes. 
 
The first atomic level structural description of substrate binding by an Hsp70 revealed 
that the 7-residue model peptide NRLLLTG (called "NR") bound in an extended, poly-
proline like conformation to a cleft in the SBD of the E. coli Hsp70, DnaK (Figure 
1.1)(Zhu et al., 1996).  
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Figure 1.1:  Structures illustrating the binding of peptide substrate models by 
Hsp70s.  
 
a) The substrate-binding domain of the E. coli Hsp70, DnaK, bound to the 
heptapeptide, NRLLLTG (PDB 1dkz).(Gragerov and Gottesman, 1994) Note that the 
peptide (purple) is in an extended conformation, cradled by the β-subdomain (green) 
and fully enclosed by the α-helical lid (red). b) A view from the top of the β-
subdomain (after removal of the α-helical lid) showing the hydrophobic pocket of the 
peptide binding site that defines the 0th subsite. Greater hydrophobicity of the SBD 
surface is indicated by the intensity of the green color. The second leucine of the 
bound NR peptide interacts with the pocket.  
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Sub-sites for side chain interaction could be identified around a central (0) site with a 
deep pocket where the second Leu bound. This hydrophobic subsite explained the strong 
bias towards an aliphatic hydrophobic residue in DnaK binding motifs. The three subsites 
of interaction in DnaK on either side of the 0th subsite (i.e., -3, -2, -1, and +1, +2, +3) 
have the potential for quite permissive interactions, and significant hydrogen bonding to 
the backbone stabilizes the bound peptide. Subsequent structural studies (summarized in 
Table A.1) have reinforced these original findings, in one case with a human Hsp70, 
(Zhang et al., 2014) and added new twists: For example, the NR model peptide was 
observed in an alternate crystal to bind in a different register, showing that the position of 
the positive charge relative to the hydrophobic residue binding to the 0th subsite is not 
critical (Zahn et al., 2013). Some peptides from antimicrobial origins reinforced this 
finding and showed that a peptide lacking a positive charge may bind, albeit with 
somewhat lower affinity (Zahn et al., 2013). Polypeptides can bind in the opposite 
orientation to the binding mode utilized in the original crystal structure of DnaK. This 
mode of binding (which I call "reverse" in Table A.1) was first seen in HscA, an Hsp70 
that is implicated in Fe-S complex assembly in E. coli, (Cupp-Vickery et al., 2004) and 
has subsequently been observed for several peptides (Table A.1)(Czihal et al., 2012; 
Tapley et al., 2005; Zahn et al., 2013). The ‘reverse’ binding mode is favored when a 
proline residue occupies the ‘0’ position regardless of the location of the positive charge 
(Tapley et al., 2005, 2006; Zahn et al., 2013).  
 
Peptide substrates act as allosteric effectors of Hsp70s, and their action on the allosteric 
conformational shifts of the chaperone are governed by their affinities of binding. This 
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relationship was elegantly demonstrated using a set of model peptides of differing 
hydrophobicity and E. coli DnaK variants with complementary mutations (Mayer et al., 
2000). The energetics of peptide binding were found to be coupled to the tendency of 
DnaK to shift from the domain undocked high affinity conformation to the high ATPase 
docked conformation: Stronger binding peptides resulted in a higher rate of ATP 
hydrolysis, showing the thermodynamic coupling of ligand-modulated allostery in 
Hsp70s and raising the question whether there are functional ramifications of the 
response to substrates of differing affinities.   
 
1.3 Protein substrates: How are protein substrates recognized and bound by 
Hsp70s? 
In their cellular roles, Hsp70s act on full-length protein substrates. Because of the difficulty 
of working with incompletely folded proteins, there is a relative paucity of structural data 
on the nature of the binding interaction between protein substrates and Hsp70s. It has been 
assumed by most of the field that binding of protein substrates is mediated by interaction 
of short highly accessible sequences with the canonical binding cleft in the SBD, analogous 
to the binding of a free peptide, and that therefore, the recognition sites in proteins would 
be those predicted based on peptide studies, and the mode of binding of Hsp70s to proteins 
would be comparable to that to peptides. In fact, this expectation has rarely been tested 
directly, and there are many questions that arise when the binding of an Hsp70 to a protein 
substrate is considered. Is the mode of recognition of a protein like that observed for model 
peptides? What happens to the rest of the substrate protein when/if an accessible 
heptapeptide motif is bound to the canonical binding groove? And most importantly, what 
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is the impact of interaction with the Hsp70 on the conformational ensemble of a protein 
substrate?  
 
In an intriguing X-ray crystal structure, Geobacillus kaustophilus DnaK molecules bound 
to their own interdomain linkers via the highly conserved hydrophobic tetrapeptide 
sequence (VVLL in G. kaustophilus)(Chang et al., 2008). This structure not only shows 
how an accessible heptapeptide sequence in a protein may bind to the canonical cleft of the 
SBD in a manner that resembles closely the way a free peptide binds, but they also lend 
credence to the possibility that Hsp70s may oligomerize by binding to their own 
interdomain linkers (Aprile et al., 2013). Oligomerization of Hsp70s has been reported by 
several investigators and proposed to be involved in regulation of their cellular activities 
(Blond-Elguindi et al., 1993; Srinivasan et al., 2012). 
 
In only a couple of cases has the expectation that proteins bind to Hsp70s using the same 
mode of binding as peptides been directly tested. Chen et al. used peptide scanning to 
identify the region of apomyoglobin that bound with highest affinity to the β-subdomain 
of the SBD of DnaK, and found that the NMR signals for these same residues were 
broadened so much as to disappear when DnaK bound to full-length apomyoglobin, again 
supporting the expectation that the protein substrate utilizes the same binding mode as 
observed for peptides (Chen et al., 2006). Similarly, Rodriquez et al. found the preferred 
DnaK-binding sequence within the E. coli heat-shock transcription factor σ32 by peptide 
scanning and also identified the sequence bound to DnaK in the context of the protein by 
proteolysis footprinting; their results showed that the same sequence bound in the context 
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of the full-length σ32 as when presented as a peptide (Rodriguez et al., 2008).  
 
Thus, it seems valid to anticipate that Hsp70s will bind linear sequences of their protein 
substrates via short (7-residue) stretches with at least an anchoring hydrophobic residue, 
and usually at least one nearby positively charged residue, as current algorithms would 
predict. Moreover, peptide studies raise the possibility that the binding sites for Hsp70s in 
proteins may bind in either of two directionalities. But how is the linear sequence 
presented for binding in the protein substrate? Do Hsp70s bind only unfolded substrates 
where linear sequences would be readily accessible? Or rather do they bind partially 
collapsed proteins via transiently accessible regions? Or do they take advantage of 
dynamic sampling of multiple conformations and select for a conformation that is 
suitable for binding? What happens to regions that are not bound? And are other sites in 
the Hsp70 apart from the canonical substrate-binding cleft in the SBD playing any role in 
binding?  
 
Taking the last question first: It has been proposed that the C-terminus of Hsp70s play a 
role in substrate binding. The Wang group reported that a truncated Hsc70 lacking the 
flexible C-terminal 10-kDa segment was unable to form a complex with a model 
unfolded protein, reduced carboxymethylated α-lactalbumin (Hu and Wang, 1996). They 
postulated that the disordered C-terminus of the Hsp70 serves as an additional interaction 
site with substrate. In addition, two groups have reported that the C-terminal region of 
DnaK is required for its full function, including in vitro refolding of protein substrates.  
Mayer et al. reported several functional defects including inability to refold luciferase 
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upon truncation of E. coli DnaK to 538, removing the flexible C-terminus plus the latter 
part of the helical lid (Mayer et al., 2000). Smock et al. found that the characteristics of 
the extreme C-terminal ~25 amino acids of bacterial Hsp70s were conserved and 
explored the role of this region in E. coli DnaK. They showed that a relatively short 
truncation (35 residues) led to loss of viability under stringent conditions (absence of 
SecB) and loss of ability to efficiently refold denatured luciferase in vitro(Smock et al., 
2011). In addition, the C-terminus of E. coli DnaK became more ordered when DnaK 
bound to a protein model substrate (a stably unfolded staphylococcal nuclease mutant) 
but not when bound to a peptide (Smock et al., 2011). These data are consistent with a 
recent observation that even the helical lid of DnaK is more dynamic at all points in the 
allosteric cycle than has previously been thought (Lai et al., 2017). Taken together these 
studies suggest that protein substrates may bind to the C-terminus of Hsp70s in addition 
to the canonical substrate-binding groove. This type of binding may serve multiple 
purposes–keeping the substrate more unfolded and also keeping the substrate in the local 
region of the chaperone even after ATP-mediated release, to facilitate re-binding if 
necessary.  
 
As a bridge between peptide substrates and full-length protein substrates, several recent 
studies have used isolated domains of protein as substrates mimics. Lee, et al. show using 
the SH3 domain, that the domain is able to interact with the ADP-bound form of the 
chaperone (Lee et al., 2015). Further studies undertaken by the Kay group using the 
DNA-binding domain of human telomere repeat binding factor 1 as a substrate show that 
the domain retains it native propensity for secondary structure while bound to the 
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chaperone (Sekhar et al., 2015, 2016). The proposed model, based on a bevy of NMR 
data, allows for unbound portions of the domain to form local secondary structure while 
simultaneously avoiding the improper long-range contacts that could lead the client 
protein to ultimately misfold.  
 
In terms of the nature of the bound protein substrate, Hsp70s can bind substrates that are 
quite unfolded or non-native or, in some instances, fully folded or near-native, provided 
their binding sites are accessible and conformationally compatible with the binding of an 
extended region in the SBD binding cleft. Pioneering studies by Fink and coworkers 
showed by fluorescence and circular dichroism that a thermally unstable fragment of 
staphylococcal nuclease is a substrate for Hsp70 at 37 °C (when it is unfolded), and this 
substrate is partially unfolded and loses its α-helical structure compared with the native 
protein when bound to the chaperone. This substrate is released from the chaperone upon 
lowering the temperature to 10 °C, which stabilizes the native fold (Palleros et al., 1994). 
Similarly, N-terminal fragments from the model substrate apomyoglobin were unfolded 
when bound to the -subdomain of the SBD of DnaK based on their lack of helicity and 
global tertiary structure (Chen et al., 2006). Note that full-length apomyoglobin is 
relatively well folded and did not interact with DnaK -SBD. Studies of another model 
substrate, a slow folding variant of ribonuclease H, showed that the DnaK-bound client 
had more secondary structure than the client refolded in the absence of chaperones, 
suggesting that the bound substrate is maintained in a conformational state that supports 
productive folding (Sekhar et al., 2012). 
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Protein substrates may retain some structure when bound. Schlecht et al. used disulfide 
cross-linking and measurement of mobility of spin labels to show that the α-helical lid of 
the SBD does not fully close around a protein substrate, as it does around a peptide, 
indicating that protein substrates may retain tertiary structure when bound (Schlecht et 
al., 2011). On the other hand, single molecule fluorescence measurements by Kellner, et 
al. indicated that a substrate protein (in this case denatured rhodanese) with a compact 
denatured state ensemble in the absence of chaperones expanded substantially in Stokes 
radius upon binding DnaK, indicating a more unfolded substrate while bound to the 
chaperone (Kellner et al., 2014). Note that initial binding of DnaJ, which caused a very 
modest expansion of denatured rhodanese, was a prerequisite to DnaK binding. These 
studies also support the idea that the Hsp70 system can accommodate structured proteins 
around the binding site, and suggest that the SBD helical lid may interact with regions of 
the client in addition to the interaction between the client heptapeptide binding motif and 
the canonical cleft of the β-subdomain of the SBD (Marcinowski et al., 2011; Schlecht et 
al., 2011). The differences in binding and interaction between protein and peptide 
substrates were also observed to carry over into distinct influences on the kinetics of ATP 
hydrolysis; BiP binding to a stably unfolded antibody decelerated the hydrolysis step of 
the ATPase cycle while peptide binding accelerated it (Mayer et al., 2003). 
 
By contrast with these examples of largely unfolded Hsp70-bound model substrates, 
among its natural substrates Hsc70 is proposed to bind to well-folded clathrin triskelions, 
but they do so via a QLMLT motif present in their C-terminal unstructured tails (Bocking 
et al., 2011). In addition, both σ32 and the glucocorticoid receptor exemplify substrates 
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wherein the Hsp70 binding site is transiently exposed in one conformation of a fluctuating, 
but not fully unfolded substrate. These last three examples illustrate the functionally critical 
role of Hsp70 chaperone binding: Interaction with the chaperone provides a nucleotide-
modulated mechanism for selecting a conformation that is optimal for the required 
downstream function. The next section describes in greater detail how the simple 
mechanism of Hsp70s has been evolutionarily matched to functions. 
 
1.4 What actions do Hsp70s perform on their substrates? 
Since the essence of the binding mechanism is the same from one Hsp70 to another, the 
adaptation of Hsp70s to specific functions must be a consequence of interactions with 
substrates and co-chaperones associated with that physiological role. For example, the 
nature of the chaperone substrate–viz., its conformational state when bound and how its 
recognition motif is presented to the Hsp70 system–can determine the action the Hsp70 
exerts on its client, and the fate of the client once released from the chaperone. As 
described above, Hsp70s in all cases bind a segment of the protein that is either stably or 
transiently exposed. This binding will energetically bias the substrate towards 
conformations in which the binding segment is accessible; in many but not all cases this 
translates into a state that is less folded than the state that existed before chaperone 
binding. Then, upon release from binding, the substrate may re-engage in the downstream 
process, be it folding or interaction with a partner. If these downstream processes fail, the 
substrate may either re-bind to an Hsp70, or be degraded. In the paragraphs below, I 
relate the way Hsp70s act on their substrates to particular physiological functions of 
Hsp70s, thus illustrating the resourcefulness of the evolutionary process: Once a 
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molecular machine has evolved to mediate a mechanistically simple function, specialized 
tasks can be facilitated by adapting the mechanism to particular needs and recruiting co-
chaperones that add diversity. 
 
1.5 Hsp70s as holdases and unfoldases 
One of the major functions that has been associated with Hsp70s in vivo is maintenance 
of the unfolded state. In the cell, this role comes into play when a nascent chain emerges 
from the ribosome upon its biosynthesis, when a protein is destined to a non-cytoplasmic 
location and must be translocated across a membrane, in general requiring that it not fold 
prematurely, and when stress leads to accumulation of partially unfolded proteins that are 
susceptible to aggregation (Figure 1.2).  
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Figure 1.2: Hsp70s function to maintain and favor the unfolded state of their 
substrates for a variety of downstream outcomes.  
 
This includes folding to the native state (N), delivery to organelles for translocation 
across membranes, and hand off to downstream chaperones (or degradation 
machinery in quality control pathways, not shown). Hsp70 binding may occur co-
translationally on a nascent chain or post-translationally to substrates that are released 
from the ribosome or stress-unfolded. Upon release from the Hsp70 interaction, the 
substrate is in an unfolded (U) or folding-competent intermediate (I) state. In this 
cartoon, the polypeptide substrate is shown in yellow with Hsp70 binding sites shown 
in cyan; an organellar targeting sequence is shown as a dashed black line. The Hsp70 
subdomains are colored blue for the NBD, green for the β-subdomain of the SBD, red 
for the α-helical lid, and black for the unstructured C-terminal segment. In this and 
subsequent figures, the Hsp70 co-chaperones (J-proteins and nucleotide exchange 
factors) are not shown for simplicity. 
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Numerous discussions have appeared in the literature (see, for example (Mattoo and 
Goloubinoff, 2014)) debating whether Hsp70s actively unfold their substrates–to wit, an 
unfoldase activity, or simply bind and restrict a substrate from folding or aggregating: a 
holdase activity.  
 
Indeed, in vitro experiments using unfolded or partially folded model substrates indicate 
that substrates released from the E. coli Hsp70 are in an unfolded conformation that can 
either spontaneously refold to the native state or misfold and then re-bind the chaperone 
system (Palleros et al., 1994; Sharma et al., 2010). Thus far, there is no experimental 
evidence that the rate of folding of the client is altered by Hsp70. For example, the 
staphylococcal nuclease model substrate studied by Fink and coworkers displayed the 
same rate of refolding after ATP-induced release from the chaperone as the free protein 
under the same conditions (Palleros et al., 1994). Similarly, Sharma et al. found using a 
stably misfolded monomeric luciferase substrate that the product released from DnaK by 
ATP folded spontaneously by kinetics that match the unassisted refolding reaction 
(Sharma et al., 2010).  
 
In contrast to their holdase activity, Hsp70s have been demonstrated in vitro to act as 
unfoldases on misfolded substrates. By contrast, when a protein is stress-unfolded in the 
cell and needs to be protected by the Hsp70 system from aggregation, it may visit either a 
completely or partially unfolded conformations that have non-native interactions. 
Recognition motifs for Hsp70 binding are hydrophobic in character so that they may be 
involved in interactions favoring collapsed states. When the substrate is non-native, it 
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will dynamically sample multiple conformations, and Hsp70 binding sites will be 
transiently accessible (Figure 1.3).  
 
  
Figure 1.3: Hsp70s can actively unfold certain folding states alone or in concert 
with other chaperones.   
 
Hsp70s can unfolded misfolded states (M) alone and partner with other chaperones, 
like ClpB to undo aggregates (A). Hsp70s must bind to accessible binding sites to 
initiate the unfolding or disaggregation reaction. The coloring scheme is the same as 
in Figure 1.2. 
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Binding of these sequences will in turn favor more unfolded conformations in a 
conformational selection mechanism, leading upon substrate release to new opportunities 
for the substrate to fold productively. Thus the roles of Hsp70s in rescuing stress-
unfolded proteins are a combination of holdase and unfoldase actions. 
  
Again, in vitro work supports these general functional actions of Hsp70s: For example, 
the stably misfolded monomeric form of luciferase described above is released from the 
DnaK chaperone system in an intermediate folding state, free of non-native interactions 
that inhibit folding because of Hsp70 action, such that the released product is capable of 
spontaneously refolding to the native state (Sharma et al., 2010). 
 
1.6 Hsp70s modulate protein substrates by conformational selection 
Hsp70 systems act on a variety of substrates that are neither unfolded nor misfolded. 
Instead, in these cases the Hsp70 recognizes either a transiently unfolded and accessible 
binding site or an unstructured segment of polypeptide chain on an otherwise folded 
substrate. The action of the Hsp70 chaperone is to shift the conformational ensemble of 
the substrate by binding to its recognition site and favoring a conformation in which this 
site remains optimally presented for chaperone interaction. Two well-characterized 
examples of this mechanism of action–the regulation of the activity of the 32 
transcription factor in bacteria (Rodriguez et al., 2008) and disassembly of clathrin cages 
in coated vesicles (Bocking et al., 2011)–illustrate the exploitation of Hsp70 action for a 
specialized function. In both examples, Hsp70s exert regulatory functions by binding 
protein segments that are accessible for chaperone binding in conformations that pre-exist 
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on the substrate’s energy landscape (in the case of 32, the partner J-protein acts upstream 
to favor exposure of the DnaK binding site). By binding and stabilizing conformations 
with the DnaK-binding motif exposed, Hsp70 interaction shifts the conformational 
equilibrium towards a functionally productive state.  
 
The physiological consequence in bacteria of DnaJ and DnaK action on 32 is the 
regulation of its proteolysis by FtsH, which turns off the heat shock response (Guisbert et 
al., 2004). When chaperones are abundant, 32 is broken down, turning off the stress 
response that up-regulates chaperone production. Rodriguez et al. showed that DnaJ 
binds segment 52 to 64 in the N-terminal domain of 32, primarily via side chain 
interactions, and causes conformational changes in the client protein: first in the domain 
to which it binds, which becomes globally destabilized, and also near the binding site for 
DnaK, which is located at residues 198 to 201, causing it to become accessible. In this 
way, DnaJ facilitates DnaK binding (Rodriguez et al., 2008). Subsequently, DnaK 
binding leads to a further conformational selection and exposure of the scissile region for 
FtsH cleavage. The model that fits all of the data posits that 32 equilibrates between a 
closed and open conformation. DnaJ binding shifts the equilibrium towards an open state 
with exposure of the DnaK binding site. DnaK binding in turn triggers the proteolytic 
action of FtsH on 32 and down-regulation of the heat shock response. 
 
Hsc70, the constitutively expressed cytoplasmic Hsp70 of higher eukaryotes, is known as 
the uncoating ATPase based on its specialized role in disassembling clathrin triskelions 
from coated vesicles during endocytosis (Chappell et al., 1987). This Hsc70 partners with 
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a specialized J-protein called auxilin, (Ungewickell et al., 1995) which associates with 
vertices of the clathrin coats, thus bringing the Hsc70 to this geometric site. Elegant 
recent studies from the Kirchhausen and Harrison groups (Bocking et al., 2011; Xing et 
al., 2010) have provided a structurally based model for the action of the Hsc70. As noted 
above, the recognition motif, QLMLT, resides on the mobile C-terminal tails of the 
clathrin molecules, which are otherwise tied up in a trimeric triskelion structure that is 
intimately linked to the coat architecture. The auxilin-targeted binding of Hsc70 
molecules to its recognition motif on one clathrin molecule puts strain on the coat 
arrangement, selecting conformations that are incompatible with stable triskelions and 
causing weakness of triskelions two vertices away. The cooperative action of several 
Hsc70s in binding to locally fluctuating C-terminal tails is sufficient to tip the balance 
towards disassembly and uncoating of the vesicle. This example of a specialized Hsp70 
function exploits the binding of an accessible sequence to effect a disassembly reaction at 
a much longer distance scale, through collaboration of several Hsc70s. 
 
As discussed in this introduction, Hsp70s have an apparently simple mechanism: They 
bind short hydrophobic sequences in extended conformations. The kinetics of their 
association and dissociation with the chaperone are enhanced by ATP binding, and 
diminished when ADP is bound. Hsp70 co-chaperones embellish this simple mechanism 
in a variety of ways: substrate delivery, cellular localization, acceleration of nucleotide 
hydrolysis, nucleotide exchange, etc. Nonetheless, the impact of Hsp70 binding on their 
substrates is biophysically intriguing: including global to local unfolding, conformational 
selection, and altered dynamics. These actions have been exploited through evolution for 
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an array of purposes, from the maintenance of an unfolded state to the disassembly of 
clathrin-coats. Hsp70s interact with a large and diverse set of substrates in vivo. For 
example, a quantitative proteomics study in E. coli found over seven hundred cytosolic 
proteins that interact with DnaK, with approximately 180 of them highly enriched on 
DnaK (i.e., high affinity binders)(Calloni et al., 2012). Findings such as a single residue 
change between the yeast Hsp70s Ssa1 and Ssa2 that determines whether they act in 
prion propagation or protein degradation, but via co-chaperone interactions and not 
substrate binding specificity, (Sharma and Masison, 2011) are tantalizingly suggestive of 
the uncharted territory that the field must explore to fully appreciate Hsp70 physiological 
roles.  
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1.7 Statement of thesis 
Despite the relatively mature nature of the chaperone field, mechanistic understanding of 
chaperones binding protein clients is noticeably lacking. Most of our knowledge 
concerning Hsp70 binding to substrates is limited to peptide substrates. This approach 
has been very fruitful in elucidating the allosteric mechanism of the chaperone itself, but 
do little to describe the effect chaperone binding has on the substrate. Specifically, such 
studies do not take into account a central question about how Hsp70s interact with a 
client that has multiple potential binding sites. Are all potential binding sites utilized?  
What is the stoichiometry(ies) of the complex(es) formed? Do multiple Hsp70s act in 
concert on a single substrate? In this thesis, I use a combined biochemical and 
biophysical approach to elucidate some answers to these questions. In Chapter 2, I 
specifically address the questions about stoichiometry of Hsp70-client protein complexes. 
I use a model system of the E. coli Hsp70, DnaK, binding with a full-length protein 
substrate, the pro-form of alkaline phosphatase, proPhoA. I dissect the binding events 
first by using model peptides derived from proPhoA as substrate mimics followed by 
expanding what is known about the ‘DnaK footprint’ using long peptides that can be 
compared more closely to the isolated protein domains used in (Lee et al., 2015; Sekhar 
et al., 2015, 2016). I determine the stoichiometry of the complex formed between DnaK 
and proPhoA, addressing model put forth in (Kellner et al., 2014; Sekhar et al., 2016). 
Lastly, I determine the location(s) of DnaK binding onto the substrate and hypothesize 
about the physical rationale for this result. To my knowledge, this is the first study of this 
scale that has been conducted on an Hsp70-client protein system.  
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CHAPTER 2 
 
HOW DNAK BINDS PROPHOA 
 
This chapter details the investigation into how the Hsp70 molecular chaperone binds a 
full-length client protein by determination of the stoichiometry(s) of the complex formed 
as well as the binding site. The work for this chapter was performed in collaboration with 
Eugenia Clerico and Wenli Meng and is being prepared for publication.  
 
2.1 Introduction 
Hsp70s are a highly conserved family of ATP-dependent molecular chaperones (Clerico 
et al., 2015; Zuiderweg et al., 2013). Much work has previously been conducted on their 
allosteric cycle and binding to peptide substrates (Rudiger et al., 1997; Zahn et al., 2013; 
Zuiderweg et al., 2013). Chaperone binding to physiological substrates is at the heart of 
their action. Recently, several studies have used isolated protein domains as substrate 
mimics (Lee et al., 2015; Sekhar et al., 2015, 2016). To date, only two studies have been 
undertaken concerning rigorous characterization of Hsp70s binding to a full-length 
protein client (Kellner et al., 2014; Rodriguez et al., 2008).  
 
Hsp70s recognize linear hydrophobic stretches within client proteins combined with 
some positive charge (Landry et al., 1992; Rudiger et al., 1997; Srinivasan et al., 2012; 
Van Durme et al., 2009). The canonical binding motif has been determined largely from 
peptide arrays; and prediction algorithms have been developed in order to predict regions 
of Hsp70 binding in novel clients (Rudiger et al., 1997; Srinivasan et al., 2012; Van 
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Durme et al., 2009). Most of these algorithms and arrays have used the E. coli Hsp70, 
DnaK. The degeneracy of the binding motif suggests that each client could have multiple 
Hsp70 recognition regions within its sequence (Blond-Elguindi et al., 1993; Rudiger et 
al., 1997). This observation has led to a predominant model in the literature whereby 
multiple Hsp70 proteins are able to bind a single client protein simultaneously (Kellner et 
al., 2014; Sekhar et al., 2016). To directly test this model, I have chosen to use a fully 
unfolded protein as a substrate for DnaK, the pro-form of alkaline phosphatase, or 
proPhoA. DnaK has been shown to interact with roughly a quarter of all newly 
synthesized proteins (Deuerling et al., 1999) and has been implicated in periplasmic 
export in E. coli (Qi et al., 2002; Teter et al., 1999; Wild et al., 1996). Alkaline 
phosphatase is an in vivo client of DnaK (Wild et al., 1993) and has previously been 
characterized with the chaperones trigger factor and SecB (Huang et al., 2016; Saio et al., 
2014). The protein proPhoA has advantages over the isolated domains used previously in 
the field due to the prevalence of multiple potential DnaK binding sites within the amino 
acid sequence. In this work, I will compare the degeneracy of each DnaK binding site to 
each other through affinity measurements and I took direct aim at the question of DnaK-
substrate complex stoichiometry. In addition, I also mapped the binding site(s) of DnaK 
on the substrate to further aid in our understanding of Hsp70-client binding.  
 
2.2 Methods 
2.2.1 Protein purification 
Wild-type DnaK was expressed and purified from BL21 cells according to the protocol 
described in (Zhuravleva et al., 2012). Mutants were expressed using the BB1553 cell 
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line described in (Zhuravleva et al., 2012). Briefly, the proteins were purified on anion 
exchange chromatography on DEAE resin followed by affinity chromatography on ATP-
linked agarose resin. After purification, DnaK was buffer exchanged into HMK buffer 
(20 mM HEPES pH 7.6, 10 mM MgCl2, 100 mM KCl) The proPhoA protein was 
expressed and purified from BL21 cells according to the protocol described in (Saio et 
al., 2014). Briefly, His-tagged proPhoA was purified using NTA-Ni resin under unfolded 
and denaturing conditions. After purification, protein was concentrated and diluted into 
buffer described in (Saio et al., 2014), (20 mM KPhos pH 7, 100 mM KCl, 3 mM BME, 
0.5 mM EDTA). Purity was assessed via SDS-PAGE. Protein concentration was 
determined via either Bradford or quantitative amino acid analysis (DnaK and mutants) 
or absorbance at 280 nm (proPhoA).  
2.2.2 Isotopic labeling 
Isotopically labeled DnaK was produced according to the protocol described in 
(Zhuravleva et al., 2012) which is modified from (Tugarinov et al., 2006). Briefly, 
protein was expressed in BL21 cells in deuterated M9 media. Methyl-labeled (2H-13C-
methyl) isotopic precursors α-ketoisovaleric acid and α-ketobutryic acid were added to a 
culture of OD600 = ~0.9 before induction of protein expression. Protein was purified as 
previously described. Following purification, protein was buffer exchanged into NMR 
buffer described in (Zhuravleva et al., 2012) (20 mM K Phos pH 7.4, 0.02 % NaN3). 10 
mM MgCl2 was added prior to NMR experiments. 
2.2.3 Competition and direct binding assays 
Dissociation constants for DnaK-peptide and DnaK-proPhoA complexes were 
determined using a competition-based binding assay (Cheng and Prusoff, 1973). 100 nM-
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250 nM DnaK was used as the receptor concentration. Peptide concentrations ranged 
from ~10 nM to ~1 mM. Peptide concentration was determined by amino acid analysis. 
Concentration of ATP was limiting at five-fold molar excess relative to the DnaK 
concentration. Concentration range of proPhoA used in the experiment was between 10 
nM-40 M. Labeled peptide was FITC-p5 from BioMatik. Labeled peptide concentration 
was kept constant at 50 nM. Labeled peptide concentration was determined via 
absorbance at 494 nm. DnaK, labeled peptide, unlabeled substrate, and ATP were 
incubated together at 4 °C overnight until ATP was completely hydrolyzed. For the direct 
binding assay, the concentration of FITC-D was kept constant at 50 nM. Fluorescence 
anisotropy measurements were taken using excitation filters at 485 nm and emission 
filiters set to 520 nm on a Biotek Syngergy G2 plate reader. Raw anisotropy values were 
converted to fraction bound according to (Montgomery et al., 1999) and fit to a Hill 
equation. Data were further processed according to (Cheng and Prusoff, 1973).  
2.2.4 Malachite green ATPase assay 
ATPase assays were conducted using a commercially available kit from BioAssay 
Systems and analyzed according to (Smock et al., 2011). DnaK concentration ranged 
from 1 M (stimulated)-5 M (unstimulated). Peptide concentration was kept constant at 
100 M.  
2.2.5 Nano-spray native mass spectrometry 
DnaK-substrate complexes were formed as previously described, with the addition of 10-
fold substoichiometric amount of DnaJ relative to DnaK. Complexes were buffer 
exchanged into 100 mM ammonium acetate pH 7.5 using Micro Bio-Spin 6 
chromatography columns. Nano-spray native mass spectrometry was conducted on 
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samples using the instrument and protocol described in (Lai et al., 2017). Molar ratios of 
1:1, 10:1, and 1:10 DnaK:proPhoA were used for complex formation.  
2.2.6 Sedimentation velocity analytical ultracentrifugation 
All samples were spun at 42,000 rpm in a Beckman Coulter Proteome Lab XL-I 
analytical ultracentrifuge. Sedimentation was followed via absorbance at 280 nm. Wild-
type DnaK and T199A were analyzed at concentrations of 13 M, 26 M, and 37 M. 
The ADP/ATP concentration in the T199A samples was 20 M and 100 M, 
respectively. The proPhoA protein was analyzed at concentrations of 6 M, 12 M, and 
18 M. Protein concentrations were chosen to give a wide dynamic range and good 
signal to noise. Complexes were formed as previously described with the minor 
component at 6 M. Molar ratios tested for the DnaK-excess complexes were 1:1, 2:1, 
3:1, 4:1, and 5:1 DnaK:proPhoA. Molar ratios tested for the proPhoA-excess complexes 
were 1:2, 1:3, and 1:4 DnaK:proPhoA. Raw data were analyzed with the program 
SEDFIT (Schuck, 2000) with the continuous c(s) distribution model (Brown and Schuck, 
2006). 
2.2.7 Methyl-TROSY NMR 
Labeled protein and deuterated buffer were prepared as previously described. Labeled 
DnaK concentration was 78 M. Unlabeled substrate ranged from 20 M (proPhoA) to 
~500 M (peptides). Complexes in the absence of DnaJ were formed as previously 
described in this thesis. Data were collected using a Bruker 600 MHz spectrometer 
equipped with a cryoprobe at 25 °C. Acquisition parameters for the 1H-13C-transverse-
relaxation optimized spectroscopy (TROSY) experiments were similar to those reported 
in (Sekhar et al., 2015) and (Zhuravleva et al., 2012). Datasets were analyzed using 
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NMRPipe (Delaglio et al., 1995) and visualized with Sparky according to (Sekhar et al., 
2015).  
 
2.3 DnaK binding proPhoA 
Alkaline phosphatase (proPhoA) had previously been used as a model substrate upon 
which a DnaK binding site prediction algorithm was built (Rudiger et al., 1997). Rather 
than apply the developed algorithm (Rudiger et al., 1997), or suitable alternative 
(Srinivasan et al., 2012; Van Durme et al., 2009), I decided to use the data from the 
peptide array that were available (Rudiger et al., 1997) to determine the potential DnaK 
binding sites within proPhoA (Figure 2.1).  
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Figure 2.1. Previously published peptide array.   
 
Site ‘A’ is shown in orange, site ‘B’ is shown in purple, site ‘C’ is shown in blue, site 
‘D’ is shown in pink, site ‘E’ is shown in red, and site ‘F’ is shown in black. The 
labeling scheme designates the five potential binding sites A-E in order of appearance 
from the N- to C-terminus. A sixth site, peptide F was selected to act as a negative 
control. Peptide array figure is taken from (Rudiger et al., 1997). 
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Densitometry of the published peptide array reveals five distinct sites with proPhoA as 
having the highest concentration of DnaK bound. These five potential DnaK binding sites 
within proPhoA were synthesize as model peptides with flanking arginine tags used in 
increase their solubility (Figure 2.2).  
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Figure 2.2. Summary of the published peptide array.   
 
Site ‘A’ is shown in orange, site ‘B’ is shown in purple, site ‘C’ is shown in blue, site 
‘D’ is shown in pink, site ‘E’ is shown in red, and site ‘F’ is shown in bold. The 
numbering scheme labels the periplasmic signal sequence as negative numbers with the 
‘first’ residue being the beginning of the mature protein. Summary based on the peptide 
array conducted in (Rudiger et al., 1997). 
  
-20         -10         -1 1       10         20 
 MK  QSTIALALLP LLFTPVTKAR TPEMPVLENR AAQGDITAPG 
 
             30         40         50         60 
     GARRLTGDQT AALRDSLSDK PAKNIILLIG DGMGDSEITA 
 
             70         80         90        100 
     ARNYAEGAGG FFKGIDALPL TGQYTHYALN KKTGKPDYVT 
 
            110        120        130        140 
     DSAASATAWS TGVKTYNGAL GVDIHEKDHP TILEMAKAAG 
 
            150        160        170        180 
     LATGNVSTAE LQDATPAALV AHVTSRKCYG PSATSEKCPG 
 
            190        200        210        220 
     NALEKGGKGS ITEQLLNARA DVTLGGGAKT FAETATAGEW 
 
            230        240        250        260 
     QGKTLREQAQ ARGYQLVSDA ASLNSVTEAN QQKPLLGLFA 
 
            270        280        290        300 
     DGNMPVRWLG PKATYHGNID KPAVTCTPNP QRNDSVPTLA 
 
            310        320        330        340 
     QMTDKAIELL SKNEKGFFLQ VEGASIDKQD HAANPCGQIG 
 
            350        360        370        380 
     ETVDLDEAVQ RALEFAKKEG NTLVIVTADH AHASQIVAPD 
 
            390        400        410        420 
     TKAPGLTQAL NTKDGAVMVM SYGNSEEDSQ EHTGSQLRIA 
 
            430        440 
     AYGPHAANVV GLTDQTDLFY TMKAALGLK         
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In order to validate the ability of each potential DnaK binding site to bind DnaK as a 
small model peptides, I designed peptides including the identified proPhoA sequences 
along with flanking arginine tags, in order to increase the solubility of the peptides (Table 
A.2). Validation of the ability of the model peptides to bind DnaK was determined 
through the measurement of the binding affinity of DnaK for each of the peptides. The 
binding affinity was measured using a competition-based assay, first described by (Cheng 
and Prusoff, 1973). A fixed concentration of DnaK was incubated with a fixed 
concentration of labeled peptide (FITC-p5), and a titration of unlabeled competitor 
peptide was performed. A decrease in the fluorescence anisotropy of the labeled peptide 
was indicative of displacement of FITC-p5 from the canonical peptide binding groove on 
DnaK by the unlabeled peptide. The data were fit with a Hill equation and further treated 
with the Cheng-Prusoff equation as is necessary for this type of experiment (Cheng and 
Prusoff, 1973). The Cheng-Prusoff treatment is required in order to account for the 
amount of unlabeled peptide that is required to remove the bound FITC-p5 ligand. The 
equation and derivation can be found in Appendix. The data for four of the five peptides 
is shown in Figure 2.3.  
 
 
  
34 
 
 
 
Figure 2.3. Competition-based binding assay using the short ‘core’ proPhoA-
derived peptides.  
 
FITC-p5 was used as the labeled ligand. Data for peptide ‘A’ are shown in green, data 
for peptide ‘B’ are shown in purple, data for peptide ‘C’ are shown in blue, and data 
for peptide ‘E’ are shown in red. The experiments were performed in triplicate with 
error bars representing the standard error of the mean. KD values are shown in Table 
A.2. 
  
Competitor 
A 
B 
C 
E 
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The data for all four peptides show good signal to noise and fit well to a Hill equation. 
One of the peptides, D, aggregated during the course of this experiment and made 
determine of its binding affinity to DnaK impossible to determine through this method. 
Instead, peptide D was synthesized with a FITC tag and the binding affinity was 
measured in a direct binding assay as in (Montgomery et al., 1999). The data can be 
found in Figure 2.4. 
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Figure 2.4. Direct binding assay using FITC-tagged ‘core’ peptide D.  
 
The experiments were performed in triplicate with error bars representing the standard 
error of the mean. Increasing concentrations of DnaK were titrated against a fixed 
concentration of FITC-D peptide. KD value is shown in Table A.2.  
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All five peptides bind DnaK with roughly similar affinity. Tabulation of the dissociation 
constant values can be found in Table A.2. As a negative control, the binding affinity of a 
peptide that was not anticipated to bind DnaK, termed Peptide F, was measured and is 
shown in Figure 2.5.  
  
Figure 2.5. Competition-based binding assay using the negative control peptide, 
Peptide F. 
 
FITC-p5 was used as the labeled ligand. Data for peptide F are shown in black. The 
binding curve for peptide F does not saturate, indicating that it does not bind tightly to 
DnaK and thus acts as an effective negative control for the competition-based binding 
experiments. The experiments were performed in triplicate with error bars representing 
the standard error of the mean. KD values are shown in Table A.2. 
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The sequence of peptide F and its affinity for DnaK can be found in Table A.2. Of 
particular note is the modestly decreased affinity of peptide C relative to the other 
peptides tested. Analysis of the represented binding site shows the presence of a proline 
residue within the region of interest. If proline were to occupy the 0th position within the 
canonical peptide binding groove on DnaK, an affinity penalty is often incurred, that is 
‘reverse’ orientation peptides bind with a lower affinity when compared to their ‘forward’ 
orientation counterparts (Zahn et al., 2013). As the binding affinity of peptide C is higher 
compared to peptides that bind solely in the reverse orientation, I hypothesized that 
peptide C was binding in a mixture of the forward and reverse orientations. To test this 
hypothesis, a modified version of peptide C, dubbed peptide C’ was synthesized with a 
leucine residue in place of the proline residue and the binding affinity was measured as 
previously described. The peptide sequence can be found in Table A.2. The binding data 
are shown in Figure 2.6. 
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Figure 2.6. Competition-based binding assay using the ‘forward-only’ Peptide C 
variant (Peptide C’).   
 
FITC-p5 was used as the labeled ligand. Data for peptide C’ are shown in maroon. The 
removal of a proline residue from the peptide sequence caused an increase in binding 
affinity, consistent with the abolishment of a ‘reverse’ binding orientation. The 
experiments were performed in triplicate with error bars representing the standard error 
of the mean. KD values are shown in Table A.2. 
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The tighter binding affinity for peptide C’ as compared to peptide C is consistent with the 
abolition of the reverse binding orientation (Table A.2).  
 
A general observation about the peptides to this point is that they all bind DnaK with 
roughly similar affinity. An exception is made for peptide C, presumably due to the 
presence of reverse binding orientation. Peptide D also has modestly lower affinity, but 
care must be taken with regard to this conclusion as the binding affinity was measured 
using a different assay compared to the other peptides. All peptides show similar extent 
of stimulation of the ATPase rate of DnaK, which is known to correlate with binding 
affinity to DnaK (Figure 2.7) 
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Figure 2.7. ATPase rate stimulation of DnaK by the ‘core’ peptides.   
 
ATPase rates of DnaK in the absence and presence of each ‘core’ proPhoA peptide as 
well as the model peptides NR and p5 are shown. Peptide concentration was kept 
constant at 100 M. All peptides, except peptide F, show significant stimulation. The 
greater stimulation of ATPase rate for the p5 peptide is consistent with the higher 
binding affinity. All proPhoA-derived peptides show a similar ATPase rate stimulation 
consistent with the competition-based binding assay results. Error bars represent 
standard deviation. 
  
42 
 
Having validated that all of the potential binding sites are able to bind DnaK as model 
peptides, I hypothesized that the binding interaction between DnaK and the sites in 
question was not necessarily limited to the ‘core’ residues I had identified. This is based 
on the observation that a single DnaK binding site did not show significantly higher 
binding affinity compared to the others. In order to test this hypothesis, I designed new 
extended peptides with four residues up and down stream of the previously identified 
sites. These peptides do not have solubility tags as the flanking residues are frequently 
charged and therefore positively contribute to the solubility of the peptide. Despite this, 
peptide A was synthesized as longer relative to the other four peptides due to solubility 
constraints. The peptides can be found in Table A.2. I measured the binding affinity of 
the peptides using the previously described competition-based assay. The family of 
binding curves can be found in Figure 2.8 and the tabulated data can be found in Table 
A.2.  
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Figure 2.8. Competition-based binding assay using the extended proPhoA-derived 
peptides.  
 
FITC-p5 was used as the labeled ligand. Data for peptide ‘A’ are shown in green, data for 
peptide ‘B’ are shown in purple, data for peptide ‘C’ are shown in blue, data for peptide D 
are shown in pink, and data for peptide ‘E’ are shown in red. The experiments were 
performed in triplicate with error bars representing the standard error of the mean. KD 
values are shown in Table A.2. 
  
Competitor 
Extended A 
Extended B 
Extended C 
Extended D 
Extended E 
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Unlike with the shorter ‘core’ peptides, not all of the extended peptides have the same 
binding affinity for DnaK. With the exception of extended peptide A, all of the extended 
peptides show a marked decrease in affinity for DnaK, on the order of two-fold (extended 
D) to an order of magnitude (extended peptides B, C, and E). Extended peptide A is the 
exception to this observation, the binding affinity is not drastically altered between the 
‘core’ and extended variants. It is difficult to make comparisons between extended 
peptide A and the other extended peptides as the length is different (necessitated due to 
solubility limits on the peptide) and thus the experiments are not perfectly controlled. 
Interestingly, extended peptide D did not aggregate under the conditions used in this 
experiment.  
 
Just as with the ‘core’ peptides, stimulation of the ATPase rate of DnaK should directly 
correlate with binding affinity (Mayer et al., 2000). ATPase rate studies were performed 
using the extended peptides as substrates for DnaK (Figure 2.9).  
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Figure 2.9. ATPase rate stimulation of DnaK by the extended peptides.   
 
ATPase rates of DnaK in the absence and presence of each extended proPhoA peptide. 
Peptide concentration was kept constant at 100 M. Extended ‘A’ peptide is labeled 
AX, extended ‘B’ is labeled BX, extended ‘C’ is labeled CX, extended ‘D’ is labeled 
DX, and extended ‘E’ is labeled EX. Peptide AX showed little ATPase rate stimulation 
in DnaK, the opposite of the anticipated response. Error bars represent standard 
deviation. 
  
46 
 
 
The hierarchy of affinities and ATPase stimulation rates between the extended peptides 
indicates that the interaction between DnaK and the sites may not be limited to the ‘core’ 
binding sites that have been previously identified as these differences only arise with the 
extended peptides. In order to compare the most physiological context within which 
DnaK would likely encounter these binding sites, the affinity between DnaK and the 
entire full-length proPhoA substrate was tested using the previously described 
competition-based assay. The binding curve and dissociation constant can be found in 
Figure 2.10. 
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Figure 2.10. Competition-based binding assay using the full-length proPhoA 
protein.  
 
FITC-p5 was used as the labeled ligand. The binding curve for proPhoA binding to 
DnaK is shown in tomato. The experiments were performed in triplicate with error 
bars representing the standard error of the mean. KD values are shown in Table A.3. 
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The binding curve for proPhoA to DnaK shows a comparable affinity to the ‘core’ 
peptides as opposed to the extended peptides (Tables A.2 and A.3). A preliminary 
conclusion from these data would be that DnaK is predominantly binding at site A. In 
addition, the Hill coefficient for these data naturally ‘floated’ close to one (0.98), 
potentially indicating that a 1:1 complex may be formed between DnaK and proPhoA. An 
alternative model is that the ‘core’ residues of the binding site determine the affinity for 
DnaK. The flanking regions are present to act as gatekeepers (Sant'Anna et al., 2014), 
due to their positive effects on solubility, and further regions of the client protein act to 
modulate the potentially negative effect the flanking residues would have on chaperone 
binding.   
 
One potential region of DnaK that could interact with these ‘further regions’ of proPhoA 
is the C-terminal tail (Koldewey et al., 2017). Previously shown to be essential for full-
chaperone function (Smock et al., 2011), the mechanistic role of the C-terminal tail of 
DnaK has yet to be elucidated. If the hypothesis that the C-terminal tail is responsible for 
modulating the negative effects of the flanking residues on binding affinity is correct, 
mutant versions of DnaK in which the C-terminal tail residues are altered and have 
previously been shown to be deficient in chaperone activity (D628A) should show a 
decrease in binding affinity for the full-length proPhoA substrate. The binding data are 
shown in Figure 2.11 and Table A.3. 
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Figure 2.11. Competition-based binding assay comparing wild-type DnaK and 
D628A using the full-length proPhoA protein.  
 
FITC-p5 was used as the labeled ligand. The binding curve for proPhoA binding to 
wild-type DnaK is shown in tomato. The binding curve for proPhoA binding to 
D628A DnaK is shown in goldenrod. The experiments were performed in triplicate 
with error bars representing the standard error of the mean. KD values are shown in 
Table A.3. 
Mutant 
Wild-type 
D628A 
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There is no appreciable difference between the binding affinity of wild-type DnaK and 
D628A DnaK for proPhoA. If the second proposed model is valid, the C-terminal tail of 
DnaK is unlikely to be responsible for modulating the effects of the flanking gatekeeper 
residues.  
 
2.4 Stoichiometry of the DnaK-proPhoA complex 
Due to the frequency with which the canonical DnaK binding motif occurs within cellular 
proteomes, models have been put forth in the literature whereby multiple DnaK 
molecules can bind a single protein substrate simultaneously (Kellner et al., 2014; Sekhar 
et al., 2016). Kellner et al. conducted single molecule FRET experiments with a labeled 
rhodanese construct an unlabeled chaperone (Kellner et al., 2014). They observed an 
increase in the inter-label distance when chaperone was bound to the substrate. These 
histograms were then computationally modeled in an attempt to determine the number of 
DnaK molecules that were bound to a single rhodanese substrate (Kellner et al., 2014). It 
was assumed that a substrate with multiple DnaK molecules bound would decrease the 
FRET efficiency linearly as a result of chaperone binding. Based on the results of the 
modeling, it was reported that 6-7 DnaK molecules could bind a single substrate (Kellner 
et al., 2014).  
 
No single ‘core’ binding site appears to have a significantly higher affinity for DnaK 
compared to the others, consistent with their observations. It stands to reason therefore, 
that two competing models emerge. First, termed the single-site binding model, DnaK 
binds at one and only one site. Second, DnaK is evenly distributed throughout the 
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identified binding sites within proPhoA according to some distribution based on the 
affinity of DnaK for each site. This second model is termed the multiple-site binding 
model. Both binding models are shown in Figure 2.12.  
 
  
Figure 2.12. Two possible DnaK-substrate binding models.  
 
(A) Cartoon depiction of the single-site binding model resulting from one dominant 
binding site. (B) Cartoon depiction of the multiple site-binding model where DnaK 
is evenly distributed throughout the available binding sites on the substrate.  
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To differentiate between these two models, I sought to determine the stoichiometry with 
which DnaK and proPhoA form a complex. The Hill coefficient from the DnaK-proPhoA 
binding curve suggests that the complex formed may be 1:1. In collaboration with 
Eugenia Clerico, we performed nano-spray native mass spectrometry on DnaK-proPhoA 
complexes at different molar ratios of each component. The complexes were formed in 
the presence of DnaJ. The results are shown in Figure 2.13. 
 
  
Figure 2.13. Nano-spray native mass spectrometry of DnaK-proPhoA 
complexes shows a 1:1 stoichiometry.  
 
The top panel shows that when incubated at equal molar ratios with limiting ATP, 
DnaK and proPhoA only form a 1:1 complex. The middle panel shows that when 
DnaK is incubated with a ten-fold excess of proPhoA, only a 1:1 complex is seen. A 
1:2 DnaK:prophoA complex is observed, but is believed to be an artifact of the 
hydrophobicity of the unfolded proPhoA substrate. The bottom panel shows that 
when ten-fold excess DnaK is added relative to proPhoA, still only a 1:1 complex is 
formed.  
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Strikingly, even at a ten-fold molar excess of DnaK relative to proPhoA, only a 1:1 
DnaK:proPhoA complex is observed. Alternate stoichiometries of 1:2 and 2:2 
DnaK:proPhoA complexes were observed in the sample with ten-fold excess of proPhoA. 
As proPhoA is an unfolded protein under the conditions that we used (described in 
(Huang et al., 2016; Saio et al., 2014)), it is possible that the alternate stoichiometries are 
gas-phase artifacts that are a result of the Coloumbic explosion of the electrospray 
droplet. The use of nano-spray instead of standard direct injection methods reduces the 
likelihood of these artifacts forming, but it still remains within the realm of possibility 
(Kebarle and Verkerk, 2009).  
 
In order to study the alternate stoichiometry complexes, I sought a method to determine 
the stoichiometry of the complex in solution. For obvious reasons, this would eliminate 
the possibility that the observed complexes are gas-phase artifacts. To this end, I 
employed analytical untracentrifugation as the method of choice (Cole et al., 2008). In 
particular, sedimentation velocity experiments have been used under similar conditions to 
the ones I employ here (Balbo et al., 2005).  
 
There are several factors that need to be accounted for in both the experimental design 
and data analysis in order to rigorously answer the proposed question. First, DnaK and 
proPhoA will form a non-covalent complex. The nature of this complex suggests that 
some population of the complex will dissociate and re-associate over time. This 
complicates the use of SV because the system is examined as a function of time. Non-
covalent complexes have been treated via SV AUC as found in (Brown et al., 2008; 
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Schuck, 2013). In addition, mixtures of components have been successfully treated in 
(Balbo et al., 2005). To address some of these issues, the DnaK-proPhoA complex will be 
pre-formed in the absence of DnaJ, as previously described, before analysis using SV 
AUC. The SV-AUC will provide a description of the complex after ATP has been 
completely hydrolyzed, namely the distribution of both the complexes formed as well as 
the free components.  
 
The nature of both DnaK and proPhoA presents challenges in applying the SV AUC 
technique. In the apo-nucleotide and ADP-bound form, DnaK exists as a two-domain 
protein with the two domains acting as largely independent units. In the ATP-bound 
form, the two domains dock, and the protein more closely resembles a single globular 
protein. The SV AUC experiments were conducted with DnaK in either the apo-
nucleotide or ADP-bound state. The proPhoA model substrate presents its own set of 
challenges. The protein, as prepared, is largely unfolded. This conformational flexibility 
may need to be accounted for in the data analysis of both the control samples as well as 
the complexes.  
 
In addition, both proteins have the capacity to self-associate. The model substrate 
proPhoA is predominantly monomeric up to 40 μM. DnaK highly soluble and largely 
monomeric. Some oligomerization of DnaK has been reported, but the extent of this 
behavior is currently unknown (Schonfeld et al., 1995; Thompson et al., 2012). The SV 
AUC experiment as designed is particularly powerful because it allows label-free 
analysis of the system in native buffer.  
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Below is shown a dilution series of proPhoA spanning the dynamic range of the 
absorbance spectrophotometer in the instrument. Below are shown selections of the raw 
data, the treated data set combined with the relevant residuals plots describing the fit of 
the model to the raw data (Figure 2.14). 
  
Figure 2.14. Dilution series of proPhoA.  
 
Above is shown a dilution series of proPhoA. Panels A-C show 6 µM, panels D-F 
show 12 μM, and panels G-I show 18 µM proPhoA. A, D, and G. A selection of 
the raw data (every 10 scans) is shown. The boundary indicates that the sample is 
sedimenting over time. The signal-to-noise (S/N) is adequate for panel A and quite 
good for panels D and G. The raw data were analyzed using the c(s) distribution 
model in SEDFIT. The resulting c(s) distributions are shown in panels C, F, and I. 
All three panels show peaks consistent with monomer and dimer proPhoA 
(labeled). Panels B, E, and H show the residuals plot for the raw data (A, D, G) fit 
to the c(s) distributions (C, F, I). All three residuals plots are small relative to the 
raw data and show little to no structure. Peaks consistent with artifacts in the data 
analysis are marked with an asterisk. 
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The raw data show adequate signal-to-noise (S/N) for 2.14A and quite good S/N for 
2.14D and 2.14G. All panels indicate that the sample is sedimenting over time. A single 
boundary is seen for all scans. The data were analyzed using the c(s) distribution model 
in SEDFIT (Schuck, 2000). This model assumes ideal sedimentation and spherical 
particles. The raw data are fit to numerical solutions of the Lamm equation. As a result, 
the sedimentation coefficient, frictional ratio, and diffusion constant are co-dependent in 
this analysis. The relatively dilute concentrations of protein used do not violate the 
assumption of ideal sedimentation. The spherical particle assumption can be violated in 
the analysis by fitting the frictional coefficient to the data. Key parameters for the data 
analysis were fitting the frictional coefficient and meniscus position, buffer density and 
viscosity (calculated in SEDNTERP), fitting time independent noise, and constraining the 
maximum radial distance for the raw data analysis as well as sedimentation coefficient 
range that was explored (Harding et al., 1992). The range for all data sets was between 
0.2 S and 20 S. This is roughly a range from something unphysical (0.2 S), to 1 MDa. All 
of the protein samples and complexes are expected to fall in this range.  
 
The raw data were treated in the above way to generate the c(s) distributions shown in 
panels 2.14C, 2.14F, and 2.14I. The models are good fits to the data as shown by the 
rmsd values found in Table A.4. In addition, the residuals plots shown in 2.14B, 2.14E, 
and 2.14H are all small relative to the raw data and show little to no structure. Peaks 
consistent with artifacts due to the fitting procedure are marked with an asterisk. An 
overlay of the three c(s) distributions shown in Figure 2.14 is shown in Figure 2.15. 
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Figure 2.15. Dilution series of proPhoA c(s) distribution overlays.  
 
Above is shown the overlay of the c(s) distributions shown in Figure 1. 6 µM is 
shown in red, 12 µM in green, and 18 μM in blue. Relevant peaks are marked with 
colored shapes. Sedimentation coefficient values for the labeled peaks are found in 
Table A.4. Average of purple circle (PC) is 3 S. Average of yellow star (YS) is 4.7 S 
± 0.23 S. Asterisks denote peaks consistent with artifacts arising in the data analysis.  
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The sedimentation coefficient values shown are fit from the raw data. The diffusion term 
is fit in the c(s) distribution analysis. The diffusion constant can be measured, however, 
using a different analysis model. This alternate model still suffers from the same 
shortcomings as the c(s) distribution in that the parameter is a fit quantity. The frictional 
coefficient is fit to the data and is contained in the diffusion term in the data analysis. The 
rmsd values of each fit are on the order of 10-3 and therefore the model is a good fit to the 
data. 
 
The data collected are consistent with a large (>75%) component of monomer for 
proPhoA and are quantitative with regard to the relative intensity of the peaks. The 
relative percentage of higher-order proPhoA oligomer increased as a function of 
concentration. The sedimentation coefficient of the PS peak is consistent with a proPhoA 
monomer while the YS peak is consistent with a proPhoA dimer. The sedimentation 
coefficient of the YS peak changes slightly as a function of concentration, indicating the 
possibility of self-association. The potential self-association is not a dimer in the 
traditional sense, meaning a form that has an appreciable dissociation constant and 
consequently longer stability. Reversible self-association refers to a relatively transient 
interaction, one that is better described by kinetic on/off rates in the mili-to-microsecond 
range rather than equilibrium dissociation constants (Dam and Schuck, 2005).  
 
I performed SV AUC on a dilution series of DnaK ranging between 13 µM-37 µM. 
Analyzing DnaK separately was performed to determine the extent to which the 
conformational flexibility of the protein would impact the data analysis of the complexes. 
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In addition, the concentration range chosen would be useful for assessing the presence of 
oligomerization status of DnaK. DnaK was in the apo nucleotide state. Below are shown 
selections of the raw data, the treated data set combined with the relevant residuals plots 
describing the fit of the model to the raw data (Figure 2.16). 
Figure 2.16. Dilution series of DnaK.  
 
Above is shown a dilution series of DnaK in the apo-nucleotide state. Panels A-C show 
13 µM, panels D-F show 26 μM, and panels G-I show 37 µM DnaK. A, D, and G. A 
selection of the raw data (every 10 scans) is shown. The boundary indicates that the 
sample is sedimenting over time. The signal-to-noise (S/N) is adequate for panel A and 
quite good for panels D and G. The raw data were analyzed using the c(s) distribution 
model in SEDFIT. The resulting c(s) distributions are shown in panels C, F, and I. 
Panels C, F, and I do not show a peak consistent with monomeric DnaK (labeled). 
Some peaks are consistent with higher-order oligomerized DnaK in panels F and I.  
Panels B, E, and H show the residuals plot for the raw data (A, D, G) fit to the c(s) 
distributions (C, F, I). All three residuals plots are small relative to the raw data and 
show little to no structure.  Large spikes in the residuals plots are from the first scan due 
to incomplete formation of the boundary. Peaks consistent with artifacts in the data 
analysis are marked with an asterisk.  
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An overlay of the c(s) distributions can be found in Figure 2.17.  
  
Figure 2.17. Dilution series of w/t DnaK c(s) distribution overlays. Above is shown 
the overlay of the c(s) distributions shown in Figure 3. 13 µM is shown in red, 26 µM in 
green, and 37 μM in blue. Relevant peaks are marked with colored shapes. 
Sedimentation coefficient values for the labeled peaks are found in Table A.5. Average 
of purple circle (PC) is 3.13 S ± 0.12 S. Average of orange square (OS) is 5.06 S ± 0.12 
S. Average of yellow star (YS) is 7.3 S ± 0.1 S. Asterisks denote peaks consistent with 
artifacts arising in the data analysis.  
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Apo-nucleotide DnaK does not behave as expected. Specifically, three species are 
observed in the c(s) distributions when only one or two were anticipated. It was 
hypothesized that the conformational flexibility of apo nucleotide DnaK is causing some 
of the inherent assumptions in the data analysis to breakdown. In order to test this, I 
performed a control experiment with ATP-bound T199A DnaK. The T199A mutation 
impedes ATP hydrolysis, but does not affect nucleotide binding (Zhuravleva et al., 2012). 
The same conditions were tested as for the wild-type sample, except for the presence of 
ATP. Below is shown the results of the ATP-bound T199A dilution series experiment 
(Figure 2.18).  
  
Figure 2.18. Dilution series of ATP-bound T199A.  
 
Above is shown a dilution series of ATP-bound T199A. Panels A-C show 13 µM, 
panels D-F show 26 μM, and panels G-I show 37 µM DnaK. The 13 µM contained 
20 µM ATP, while the 26 µM and 37 µM samples contained 100 µM ATP. A, D, 
and G. A selection of the raw data (every 10 scans) is shown. The boundary 
indicates that the sample is sedimenting over time. The signal-to-noise (S/N) is 
adequate for panel A and quite good for panels D and G. The raw data were 
analyzed using the c(s) distribution model in SEDFIT. The resulting c(s) 
distributions are shown in panels C, F, and I. Panels C, F, and I. show a 
predominant peak consistent with monomeric DnaK (labeled). Some peaks are 
consistent with dimeric DnaK.  Panels B, E, and H show the residuals plot for the 
raw data (A, D, G) fit to the c(s) distributions (C, F, I). All three residuals plots are 
small relative to the raw data and show little to no structure.  Large spikes in the 
residuals plots are from the first scan. Peaks consistent with artifacts in the data 
analysis are marked with an asterisk.  
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An overlay of the c(s) distributions for the ATP-bound T199A experiment can be found 
in Figure 2.19. 
  
Figure 2.19. Dilution series of ATP-bound T199A c(s) distribution overlays.  
 
Above is shown the overlay of the c(s) distributions shown in Figure 4. 13 µM is 
shown in red, 26 µM in green, and 37 μM in blue. Relevant peaks are marked with 
colored shapes. Sedimentation coefficient values for the labeled peaks are found in 
Table A.6. Average of purple circle (PC) is 3.8 S. Average of yellow star (YS) is 5.83 
S ± 0.06 S. Asterisks denote peaks consistent with artifacts arising in the data 
analysis.  
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The conformational dynamics of DnaK complicate the study of this system by SV AUC. 
The fitting algorithm used by SEDFIT allows for the fitting of the frictional ratio to 
ensure that the sedimentation coefficient and diffusion constant can be related and 
achieve a good fit for the data. The limitation of this approach is that only a single, or 
sometimes up to two, frictional coefficients are applied to every peak in the c(s) 
distributions. In essence, the analysis process treats every particle as having the same 
shape. For a dynamic protein like DnaK, this presents a problem. The variable shape, and 
consequently frictional coefficient, is treated by SEDFIT as belonging to two major 
population species, ones that have sedimentation coefficients shown in Figure 2.19. The 
rmsd values of each fit are on the order of 10-3 and therefore the model is a good fit to the 
data. Despite this, some c(s) distributions show a low molecular weight peak of ~20 kDa 
(asterisk). This could be due to the presence of beta-mercaptoethanol in the buffer.  
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The hypothesis that the three peaks seen in Figures 2.16 and 2.17 were the result of poor 
fitting due to the dynamics of the protein, was tested by biasing the conformation of 
DnaK into a single state by adding ATP. Analysis of the ATP-bound T199A system 
showed sedimentation coefficients consistent with a monomer and dimer of DnaK. This 
result is consistent with the interpretation that the aberrant peaks seen in Figures 2.16 and 
2.17 are due to the conformational dynamics of DnaK. A control experiment using ADP-
bound T199A is shown in Figure 2.20.  
Figure 2.20. Dilution series of ADP-bound T199A.  
 
Above is shown a dilution series of ADP-bound T199A. Panels A-C show 13 µM, 
panels D-F show 26 μM, and panels G-I show 37 µM DnaK. The 13 µM contained 20 
µM ADP, 26 µM contained 30 µM ADP, and 37 μM contained 40 µM ADP. A, D, and 
G. A selection of the raw data (every 10 scans) is shown. The boundary indicates that 
the sample is sedimenting over time. The signal-to-noise (S/N) is adequate for panel A 
and quite good for panels D and G. The raw data were analyzed using the c(s) 
distribution model in SEDFIT. The resulting c(s) distributions are shown in panels C, F, 
and I. Panels C, F, and I. show similar behavior as compared to wild-type DnaK. No 
peak is consistent with the monomer, but at least one peak is consistent with the dimer. 
Some peaks are consistent with dimeric DnaK.  Panels B, E, and H show the residuals 
plot for the raw data (A, D, G) fit to the c(s) distributions (C, F, I). All three residuals 
plots are small relative to the raw data and show little to no structure.  Peaks consistent 
with artifacts in the data analysis are marked with an asterisk.  
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An overlay for the c(s) distributions shown in Figure 2.20 is shown in Figure 2.21.  
 
  
Figure 2.21. Dilution series of ADP-bound T199A c(s) distribution overlays.  
 
Above is shown the overlay of the c(s) distributions shown in Figure S1. 13 µM is 
shown in red, 26 µM in green, and 37 μM in blue. Relevant peaks are marked with 
colored shapes. Sedimentation coefficient values for the labeled peaks are found in 
Table A.6. Average of purple circle (PC) is 4 S. Average of orange square (OS) is 
5.6 S. Average of yellow star (YS) is 7.26 S ± 0.23 S. Asterisks denote peaks 
consistent with artifacts arising in the data analysis.  
67 
 
There are two main implications for the DnaK result. The first is that it will be 
impossible, to quantify free and bound DnaK and proPhoA in relation to each other. The 
peaks corresponding to the monomer and dimer of proPhoA occur in the c(s) distribution 
very close to the dynamic monomer peaks (PC and OS) in the DnaK c(s) distribution. As 
a result, the relative intensities of the complex and the components are qualitative. The 
second implication concerns the relative monomer/dimer amounts in DnaK itself. If these 
are quantified, the PC and OS peaks should be combined and compared to the YS peak. 
This would be consistent with the observations from the ATP-bound T199A experiment.  
 
A final word on DnaK concerns the nature of the YS peaks seen in Figure 2.17. The 
peaks do not have vertical alignment. This is indicative of reversible self-association that 
is rapid on the timescale of sedimentation. Importantly, the sedimentation coefficients 
consistent with the DnaK dimer are well separated from the sedimentation coefficient 
range associated with the monomer of DnaK and both species of proPhoA.  
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Now that each component of the DnaK-proPhoA complex has been analyzed separately, I 
can begin to look at the complex itself. I performed a titration of molar ratios of DnaK 
against a fixed concentration of proPhoA. The concentration of minor component was 
selected to be well above the KD as well as provide sufficient signal to noise to be reliably 
detectable under the conditions used. A titration of molar excess DnaK relative to a 
constant concentration of proPhoA is shown below (Figure 2.22).  
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Figure 2.22. Titration of molar excess of DnaK against a constant concentration of 
proPhoA.  
 
Above is shown a titration of DnaK against proPhoA. Panels A-C show a 1:1 ratio. 
DnaK and proPhoA concentrations were both 6 µM, with 30 μM ATP. The 
concentration of proPhoA was kept constant at 6 µM. panels D-F show 12 μM DnaK, 
60 µM ATP. Panels G-I show 18 µM DnaK, 90 µM ATP. Panels J, K, and L show 24 
µM DnaK, 120 µM ATP. Panels M, N, and O show 30 µM DnaK, 150 µM ATP. A, D, 
G, J, and M. A selection of the raw data (every 10 scans) is shown. The boundary 
indicates that the sample is sedimenting over time. The signal-to-noise (S/N) is adequate 
for panel A and quite good for panels D, G, J, and M. All panels show a single 
boundary. The raw data were analyzed using the c(s) distribution model in SEDFIT. 
The resulting c(s) distributions are shown in panels C, F, I, L, and O. Panels C, F, I, L, 
and O show peaks consistent with unbound DnaK or proPhoA. From the c(s) 
distributions, it is not possible to discern between them. Panels C, F, I, L, and O show a 
peak that is consistent with a 1:1 DnaK:proPhoA complex. No higher order complex 
corresponding to multiple DnaK molecules binding to a single proPhoA molecule are 
observed. Panels F, I, and O show a peak consistent with a DnaK dimer. Panels C, F, I, 
L, and O were treated with a Bayesian algorithm that transforms the raw c(s) 
distribution into sharp peaks for visibility purposes (Brown et al., 2007). Panels B, E, 
H, K, and N show the residuals plot for the raw data (A, D, G, J, and M) fit to the c(s) 
distributions (C, F, I, L, and O). All three residuals plots are small relative to the raw 
data and show little to no structure.  Large spikes in the residuals plots are from the first 
scan. Peaks consistent with artifacts in the data analysis are marked with an asterisk.  
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All c(s) distributions were treated with a Bayesian algorithm that models the data as sharp 
peaks (Brown et al., 2007). The logic of this step is rooted in the fact that the components 
being analyzed are discrete species. There is little to no polydispersity, as might be 
anticipated for a polymer, in the sample. The actual method of manipulation of the data is 
described in more detail in (Brown et al., 2007). The algorithm/assumption was applied 
to all c(s) distributions in Figure 2.22 to aid in visualization and interpretation. No higher-
order complex of DnaK-proPhoA corresponding to multiple DnaK molecules bound to a 
single proPhoA molecule were observed. These results are consistent with the nano-spray 
native mass spectrometry data previously collected. In addition, this observation does not 
change under complex formation conditions of up to five-fold molar excess of DnaK 
relative to proPhoA. All tabulations of the data can be found in Table A.7.  
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Next, in an attempt to validate the existence of the alternate complex stoichiometries 
observed in the nano-spray native mass spectrometry, a titration of increased 
concentration of proPhoA relative to a constant DnaK concentration was performed 
(Figure 2.23) with the results tabulated in Table A.8.  
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Figure 2.23. Titration of molar excess of proPhoA against a constant concentration 
of DnaK.  
 
Above is shown a titration of proPhoA against DnaK. Panels A-C show a 1:2 ratio. 
proPhoA concentrations was at 12 µM. Panels D-F show 18 μM proPhoA. Panels G-I 
show 24 µM proPhoA. A, D, and G show a selection of the raw data (every 10 scans) is 
shown. The boundary indicates that the sample is sedimenting over time. The signal-to-
noise (S/N) is quite good for all panels. The raw data were analyzed using the c(s) 
distribution model in SEDFIT. The resulting c(s) distributions are shown in panels C, F, 
and I. Panels C, F, and I show peaks consistent with unbound DnaK or proPhoA. From 
the c(s) distributions, it is not possible to discern between them. Panels C, F, and I, 
show a peak that is consistent with a 1:1 DnaK:proPhoA complex. No higher order 
complex corresponding to multiple DnaK molecules binding to a single proPhoA 
molecule are observed. Different peaks with molecular weights corresponding to 
alternate complexes of multiple proPhoA molecules bound to a single proPhoA are 
observed in panels F and I. Panels C, F, and I also show a 2:2 DnaK:proPhoA complex. 
Panels F and I were treated with a Bayesian algorithm that transforms the raw c(s) 
distribution into sharp peaks for visibility purposes (Brown et al., 2007). Panels B, E, 
and H show the residuals plot for the raw data (A, D, and G) fit to the c(s) distributions 
(C, F, and I). All three residuals plots are small relative to the raw data and show little 
to no structure.  Large spikes in the residuals plots are from the first scan. Peaks 
consistent with artifacts in the data analysis are marked with an asterisk.  
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Studying the DnaK-proPhoA complex via SV AUC is a daunting task. I am unable to 
draw conclusions based on the abundance of the complex, nor either of the free 
components. This means that these experiments are unable to provide a determination of 
the dissociation constant. Based on the current data, I am unable to determine the 
absolute molecular weight of the peaks because both the sedimentation and diffusion 
coefficients are co-dependent parameters.  
 
The rmsd values of each fit are on the order of 10-3 and therefore the model is a good fit 
to the data. Based on the sedimentation coefficients in the c(s) distributions, I can draw 
some conclusions relating to the DnaK:proPhoA system. First, the predominant complex 
performed between DnaK and proPhoA is 1:1. Additional DnaK, up to a five-fold molar 
excess, did not alter this stoichiometry. The sedimentation coefficient most consistent 
with the 1:1 complex varies between 5.4 S and 6.4 S in the DnaK titration experiment. 
This is a fairly large range of sedimentation coefficients and may indicate that the 
complex is associating with either itself or another component(s) in the sample. In Figure 
2.16, the sedimentation coefficient most consistent with the DnaK dimer was ~7.4 S. The 
tested conformation of DnaK was the apo nucleotide state. The ADP-bound form of 
DnaK is known to have similar dynamics, with regard to the NBD and SBD, as the apo 
nucleotide form. It is assumed that the dimer of DnaK would have a similar 
sedimentation coefficient in the DnaK-titration complex formation experiments due to the 
fact that it was ADP-bound. Using this assumption, I have assigned peaks in the c(s) 
distributions in Figure 2.22 to the 1:1 DnaK:proPhoA complex, rather than a DnaK 
dimer.  
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In the proPhoA titration experiment, the sedimentation coefficient most consistent with 
the 1:1 complex varied between 6.8 S and 7.4 S. This regime overlaps with the 
sedimentation coefficient range for the DnaK dimer seen in Figure 2.16. Ordinarily, this 
would present an unsolvable problem with the current data. Applying some judicious 
assumptions, particularly that DnaK dimer is likely to be non-existent under complex 
formation conditions with 6 μM DnaK and a molar excess, up to 4:1, of proPhoA, I am 
reasonably confident that these peaks correspond to the 1:1 complex.  
 
Alternate complexes consisting of either 1:2 or 2:2 DnaK:proPhoA were observed when 
excess proPhoA was titrated against DnaK. These complexes had been previously 
observed in nano-spray native mass spectra and were attributed at the time to gas phase 
artifacts. Based on the above data, these complexes exist in solution as well as the gas 
phase. The physiological relevance of these complexes is not currently known. It remains 
possible that these complexes are non-specific association between the bound proPhoA 
and another proPhoA molecule. This could be the case, if only a single DnaK binding site 
on proPhoA is bound. These interpretations are consistent with other interpretations 
based on nano-spray native mass spectrometry data previously collected.  
 
Several conclusions can be drawn from the above data. First, proPhoA can be well 
studied using this technique. The peak with a sedimentation coefficient consistent with a 
dimer of proPhoA shows reversible self-association. The unfolded character of proPhoA 
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does not seem to affect the analysis of the protein via SV AUC beyond increasing the 
possibility of self-association.  
 
Analyzing DnaK by SV AUC is more challenging. The dynamic nature of the protein in 
the apo nucleotide and ADP-bound forms causes the c(s) distribution to contain more 
peaks than anticipated. These peaks disappear once ATP is added. The control 
experiment was conducted with the T199A hydrolysis-deficient mutant to ensure that the 
protein did not turnover ATP over the timescale of the experiment. ADP-bound T199A 
behaved similarly to wild-type under these conditions, allowing us to be confident in our 
comparison between the two proteins. A dimer of DnaK was also present in c(s) 
distribution. This dimer was not stable on the timescale of sedimentation.  
 
Studying the DnaK-proPhoA complex via SV AUC is complex, but achievable. Due to 
the dynamics of DnaK and the resulting peaks in the c(s) distribution, the monomer of 
ADP-bound DnaK and proPhoA will overlap. This precludes using this method in a 
quantitative way for determining KD for this system. Qualitative observations can be 
made from the c(s) distributions, with the quantitative aspects being limited to the 
sedimentation coefficient distribution and relative peak abundance. A titration of 
increasing molar excess of DnaK revealed a 1:1 stoichiometry with no additional DnaK 
molecules being able to bind proPhoA. A titration of increasing molar excess of proPhoA 
revealed a 1:1 complex, no additional DnaK molecules being bound, but also two 
unanticipated complexes. Peaks corresponding to 1:2 and 2:2 DnaK:proPhoA complexes 
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were observed. These are consistent with previously observed complexes via nano-spray 
native mass spectrometry.  
 
Based on the nano-spray native ass spectrometry and sedimentation velocity analytical 
ultracentrifugation experiments, only one DnaK molecule is capable of binding a single 
proPhoA molecule simultaneously. This causes us, in this case, to reject the models put 
forth in (Kellner et al., 2014) and (Sekhar et al., 2016). In addition, it causes me to 
rethink the previous models I had put forth in Figure 2.12. The single-site binding model 
still holds water and remains unchanged. The multiple-site binding model, however, 
requires some changes. Specifically, the possibility of multiple DnaK molecules binding 
a single proPhoA molecule must be eliminated. Instead, the heterogeneous binding model 
now reflects a single DnaK binding a single proPhoA, but that DnaK occupancy of each 
site is evenly distributed throughout the population of bound proPhoA according to 
affinity. In addition, the existence of the 1:2 and 2:2 DnaK:proPhoA complexes can be 
explained in the light of the 1:1 complex stoichiometry. A model for why these 
complexes form is that if DnaK is only sequestering a single binding site on proPhoA. If 
proPhoA is unfolded, which is it, according to (Huang et al., 2016; Saio et al., 2014), then 
the other four potential DnaK binding sites are solvent exposed and able to self-associate.  
 
2.5 Determination of the DnaK binding site on proPhoA 
Distinguishing between the multiple-site binding model and the single-site binding model 
requires determine which of the potential DnaK binding sites on proPhoA is/are utilized 
by DnaK. Recent work from the Kay lab on DnaK-substrate interactions has identified 
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unique chemical shift perturbations in isoleucine residues that are substrate specific 
(Sekhar et al., 2015). Specifically, the two isoleucine residues in question, I401 and I438 
are well-positioned in the SBD of DnaK to be diagnostic for substrate binding (Figure 
2.24). 
 
 
  
Figure 2.24. Potentially diagnostic residues in the SBD.  
 
Three possible residues in the SBD of DnaK could be diagnostic for substrate 
binding. Residues I401 (the 0th residue), I438, and I462 are shown in purple spheres. 
The backbone of the SBD of DnaK is shown in cyan ribbon. The model peptide NR is 
shown in stick colored by atom. PDB ID: 1dkz 
I401 
I438 
I462 
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We took advantage of this phenomenon to determine the DnaK binding site on proPhoA. 
By isotopically labeling the DnaK protein and binding the labeled protein to unlabeled 
substrate, we can follow the binding of substrate by detecting the chemical shift 
perturbations (CSPs) within the labeled DnaK molecule. Wild-type DnaK was labeled 
according to the protocol described in (Tugarinov et al., 2006; Zhuravleva et al., 2012). 
The result of this labeling method is that only a single carbon atom within the isoleucine, 
leucine, and valine residues are labeled with the NMR active 13C nucleus. As a result, 
proteins isotopically labeled in this manner will be referred to as ‘ILV-labeled’. The 
NMR experiment was a TROSY-based 1H-13C experiment based on the pulse sequence 
described in (Pervushin et al., 1997) and experimental conditions described in (Sekhar et 
al., 2015).  
 
An NMR spectrum of the isoleucine region of wild-type DnaK, apo-nucleotide, 
containing two peaks that are diagnostic for substrate binding is shown in Figure 2.25. 
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I438 
I401 
Figure 2.25. Methyl-TROSY NMR spectrum of DnaK in the apo-nucleotide 
form.  
 
DnaK is shown in black. Peak assignments have been transferred using previously 
published data (Sekhar et al., 2015). I401 and I438 are circled in red. 72 M DnaK 
was used.  
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Despite the region of largely unresolved isoleucine peaks, the two diagnostic isoleucine 
residues (I401 and I438, marked in the above figure) are well resolved and show good 
signal. Even with the relatively poor quality of the NMR spectrum, the diagnostic peaks 
will still allow the determination of the binding site through this method.  
 
A complex between ILV-labeled DnaK and unlabeled proPhoA was formed as previously 
described. The methyl-TROSY spectrum was taken and process as previously described. 
The heterogeneous binding model, where DnaK binds to roughly all binding sites on 
proPhoA, distributed according to affinity, predicts that the I438 and I401 peaks will split 
and shift according to the CSP for each binding site. The single-site binding model 
predicts that each peak will only show a single shift, consistent with a dominant binding 
site. The DnaK-proPhoA NMR spectrum is shown in Figure 2.26. 
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Figure 2.26. Methyl-TROSY NMR spectrum of the DnaK-proPhoA complex.  
 
DnaK in the apo-nucleotide form is shown in black and DnaK-proPhoA in tomato. The 
observed shift is indicative of substrate binding. The single peak for both I438 and I401 
shown (arrow) is consistent with the single-site binding model. The split peak 
corresponds to I334. 72 M DnaK, 17.5 M proPhoA, and 200 M ATP were used in 
this experiment.  
I438 
I401 
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The single observed CSP for both residues I401 and I438 are consistent with the single-
site binding model. Outside of the residues diagnostic for substrate binding, other CSPs 
are observed. The poor quality of the NMR spectrum precludes drawing conclusions 
from these data, but they are suggestive that proPhoA may be interacting with regions of 
DnaK distal from the canonical peptide binding groove. 
 
Now that the single-site binding model has been validated in this case, the next goal was 
to determine which site DnaK is binding on proPhoA. To determine this, we turned to the 
‘core’ peptides. As DnaK residues I438 and I401 form the 0th position pocket within the 
canonical peptide binding groove, their chemical shifts will be sensitive for the ‘core’ 
peptide rather than the extended variants. In order to map the binding site ‘fingerprint’, 
NMR experiments were conducted with DnaK-peptide complexes for each ‘core’ 
peptide. Those NMR spectra are shown in Figures 2.27-2.31.  
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 Figure 2.27. Methyl-TROSY spectrum of the DnaK-peptide A complex.  
 
Dnak is in the apo-nucleotide form, shown in black, DnaK-proPhoA in tomato, 
and DnaK-Peptide A in green. The observed shift is indicative of substrate 
binding. The single peak shown (arrow) is consistent with the single-site binding 
model. The Peptide A-shifted peaks do not correspond to the PhoA-shifted 
peaks. 72 M DnaK, 594 M peptide, and 200 M ATP were used in this 
experiment.  
I438 
I401 
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 Figure 2.28. Methyl-TROSY spectrum of the DnaK-peptide B complex.  
 
DnaK is in the apo-nucleotide form and shown in black, DnaK-proPhoA in tomato, 
and DnaK-Peptide B in purple. The observed shift is indicative of substrate 
binding. The single peak shown (arrow) is consistent with the single-site binding 
model. The Peptide B-shifted peaks do not correspond to the PhoA-shifted peaks. 
72 M DnaK, 313 M peptide, and 200 M ATP were used in this experiment.  
I438 
I401 
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Figure 2.29. Methyl-TROSY spectrum of the DnaK-peptide C complex.  
 
DnaK is in the apo-nucleotide form and is shown in black, DnaK-proPhoA in 
tomato, and DnaK-Peptide C in blue. The observed shift is indicative of 
substrate binding. The doublet shown (arrows) is consistent with the single-site 
binding model with different binding registers. Neither of the Peptide C-shifted 
peaks corresponds to the PhoA-shifted peaks. 72 M DnaK, 394 M peptide, 
and 200 M ATP were used in this experiment.  
I438 
I401 
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Figure 2.30. Methyl-TROSY spectrum of the DnaK-peptide D complex.  
 
DnaK is in the apo-nucleotide form and is shown in black, DnaK-proPhoA in tomato, 
and DnaK-Peptide D in pink. The observed shift is indicative of substrate binding. The 
single peak shown (arrow) is consistent with the single-site binding model. The Peptide 
D-shifted I401 and I438 peaks corresponds directly to the PhoA-shifted peaks, 
indicating that DnaK is binding both pro- and mature PhoA at site D. 72 M DnaK, 10 
M peptide, and 83 M ATP were used in this experiment.  
I438 
I401 
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Figure 2.31. Methyl-TROSY spectrum of the DnaK-peptide E complex.  
 
DnaK is in the apo-nucleotide form and is shown in black, DnaK-proPhoA in 
tomato, and DnaK-Peptide E in red. The observed shift is indicative of substrate 
binding. The single peak shown (arrow) is consistent with the single-site binding 
model. The Peptide E-shifted peaks do not correspond to the PhoA-shifted peaks. 
72 M DnaK, 537 M peptide, and 200 M ATP were used in this experiment.  
I438 
I401 
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The CSPs observed for residues I438 and I401 in the presence of unlabeled proPhoA 
overlap with the CSPs in the presence of peptide D. This indicates that DnAK is binding 
proPhoA only at site D on proPhoA. This is consistent with the single-site binding model.  
 
As anticipated, the DnaK-peptide C NMR spectrum showed peaks splitting in addition to 
peaks shifts for diagnostic residues I438 and I401. This is consistent with the earlier 
hypothesis that peptide C is binding DnaK in a mixture of the forward and reverse 
orientations. In order to assign which of the two peaks are responsible for the ‘forward’ 
and ‘reverse’ orientations, a similar experiment was conducted with peptide C’, which is 
unable to bind in the reverse orientation. The isoleucine region of the NMR spectrum is 
overlaid with the spectrum for apo-DnaK and DnaK-peptide C complex and is shown in 
Figure 2.32.  
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I438 
I401 
Figure 2.32. Methyl-TROSY spectrum of the DnaK-peptide C’ complex.  
 
DnaK is in the apo-nucleotide form and is shown in black, DnaK-peptide C in 
blue, and DnaK-Peptide C’ in maroon. The observed shift is indicative of 
substrate binding. The doublet shown in blue is consistent with the single-site 
binding model with different binding registers. The DnaK-peptide C’ spectrum 
shows a single peak shift, consistent with the elimination of the reverse binding 
orientation. 72 M DnaK, 394 M peptide C, and 200 M ATP were used in 
this experiment.  
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The NMR spectrum of DnaK-peptide C’ shows only a single peak shift for the diagnostic 
residues, I438 and I401. This is consistent with DnaK only binding peptide C’ in a single 
orientation. Based on the increase in affinity for peptide C’ as opposed to peptide C, it 
was interpreted that DnaK is binding peptide C’ in solely the forward orientation. 
Furthermore, the CSPs for I438 and I401 in the peptide C’ NMR spectrum can be 
transferred onto the peptide C NMR spectrum. In this way, I can assign the identity of the 
‘forward’ and ‘reverse’ binding CSPs. A closer image of the CSPs for both residues I438 
and I401 is shown in Figure 2.33.  
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Figure 2.33. Blowup of diagnostic residues in the methyl-TROSY NMR 
spectra of the DnaK-peptide C & C’ complexes.  
 
(A) Residue I438. DnaK is in the apo-nucleotide form and is shown in black, 
DnaK-peptide C in blue, and DnaK-Peptide C’ in maroon. Red arrows mark the 
DnaK-peptide C peak that has been assigned the ‘forward’ orientation based on 
assignment transfer from the DnaK-peptide C’ NMR spectrum. (B) Residue 
I401 DnaK is in the apo-nucleotide form and is shown in black, DnaK-peptide C 
in blue, and DnaK-Peptide C’ in maroon. Red arrows mark the DnaK-peptide C 
peak that has been assigned the ‘forward’ orientation based on assignment 
transfer from the DnaK-peptide C’ NMR spectrum.  
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By transferring the peak assignment from the DnaK-peptide C’ NMR spectrum onto the 
DnaK-peptide C spectrum, the peaks corresponding to the ‘forward’ binding orientation 
were identified. Consequently, the peaks in the DnaK-peptide C spectrum that were not 
present in the DnaK-peptide C’ NMR spectrum have been assigned as belonging to the 
‘reverse’ binding orientation. Using the relative peak intensity combined with the known 
binding affinities for both peptides C and C’ to DnaK, I calculated the estimated binding 
affinity of DnaK for the ‘reverse’ binding orientation of peptide C. Those values can be 
found in Table A.2. 
 
2.6 Conclusions 
Based on the above data, some conclusions can be reached for this Hsp70-client protein 
system. First, the results of the competition-based binding assay on the ‘core’ proPhoA-
derived peptides show that all potential DnaK binding sites are able to bind to DnaK 
when presented as model peptides. In addition, all core peptide showed similar ATPase 
rate stimulation of DnaK. Similar assays using the extended peptide variants that include 
the flanking ‘gatekeeper’ residues indicate that the flanking gatekeeper residues largely 
decrease the affinity of DnaK for the peptides. This was anticipated based on the previous 
knowledge of DnaK binding motifs. Peptide C was of particular interest. The core variant 
of peptide C showed modestly decreased affinity for DnaK. It was hypothesized that this 
was due to the peptide binding in a mixture of the forward and reverse orientations at the 
proline residue. A variant peptide C, termed peptide C’, that was mutated to remove the 
proline residue showed an increase in affinity consistent with abolishment of the reverse 
orientation binding mode.  
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The competition-based binding experiments using the full-length proPhoA as the 
substrate showed dissociation constants similar to the core peptides (Tables A.2 and A.3). 
This suggests that the rest of the proPhoA protein is interacting with DnaK in such a way 
was as to modulate the negative effect the flanking gatekeeper residues have on the 
binding interaction between DnaK and proPhoA using the canonical peptide binding 
groove. Based on the literature (Smock et al., 2011), it was hypothesized that the 
disordered C-terminus of DnaK was at least partly responsible for this modulation. 
Competition-based binding experiments using the D628A point mutant, which had 
previously been shown to be deficient in full chaperone activity, showed no significant 
decrease in binding affinity for the proPhoA substrate. The binding data lend themselves 
to two potential models. The single-site binding model has DnaK binding at only a single 
potential binding site on proPhoA. The multiple-site binding model has Dnak distributed 
amongst the available DnaK binding sites within proPhoA in some population according 
to their affinities.  
 
Determination of the stoichiometry of the DnaK-proPhoA complex allowed us to 
differentiate between our two models. Nano-spray native mass spectrometry of the 
complex formed in the presence of DnaJ showed that only a 1:1 DnaK:proPhoA complex 
was formed. A ten-fold molar excess of DnaK showed similar results and did not force 
the formation of complexes with multiple DnaK molecules bound to a single substrate. 
Interestingly, complexes formed in the presence of ten-fold molar excess of proPhoA 
showed alternate complex stoichiometries of 1:2 and 2:2 DnaK:proPhoA complexes.  
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In order to confirm the veracity of the alternate complex stoichiometries, as well as 
independently confirm the 1:1 stoichiometry observations based via the nano-spray native 
mass spectrometry, analytical ultracentrifugation was performed.  
 
Sedimentation velocity experiments of isolated DnaK and proPhoA were able to show me 
the limits of this technique as I applied it to this system. To wit, the experimental design 
was limited to addressing the stoichiometry question, and was not adequately designed to 
confirm the observations made based on the competition-based assay binding data. In 
addition, study of isolated DnaK revealed a complication due to the dynamic nature of 
the two-domain protein that was necessary to account for in the experiments with the 
DnaK-proPhoA complex. Experiments with DnaK-proPhoA complexes formed with an 
excess of DnaK confirmed the presence of only a 1:1 DnaK:proPhoA complex. 
Experiments conducted with a molar excess of proPhoA in the complex formation 
reaction showed sedimentation coefficients consistent with 1:2 and 2:2 DnaK:proPhoA 
complexes, similar to what was observed in the nano-spray native mass spectrometry 
experiments. This suggests that these complexes are not gas-phase artifacts. The 
implications of this cause me to revise the multi-site binding model into a model whereby 
DnaK is still distributed amongst the potential DnaK binding sites in some order 
according to their relative affinities, but with DnaK only interacting with a single 
proPhoA protein at a time. In addition, the 1:1 stoichiometry is self-consistent with the 
observation of 1:2 and 2:2 complexes formed in the presence of excess proPhoA. If 
DnaK is only occupying a single binding site on proPhoA, presumably the other potential 
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DnaK binding sites are solvent exposed and thus able to self-associate into the 1:2 and 
2:2 complexes.  
 
The next goal was to determine which binding site(s) DnaK is occupying on proPhoA. 
DnaK that has been ILV-methyl labeled was incubated with unlabeled proPhoA. For two 
residues that are diagnostic for substrate binding, only a single CSP was observed, 
consistent with the single-site binding model. Mapping the CSP fingerprint back onto the 
peptides indicates that DnaK is binding proPhoA only at site D. Interestingly, the NMR 
spectrum of DnaK-peptide C showed two CSPs for the diagnostic residues. This is 
consistent with my hypothesis that DnaK is binding peptide C in a mixture of the forward 
and reverse orientations. Using peptide C’ as the forward orientation-only control, the 
shifted peaks were assigned either the forward or reverse orientation. Using the affinity 
for peptides C and C’ combined with the orientation assignment from peptide C’, and 
relative intensities of each peak, I was able to estimate the binding affinity of DnaK for 
the reverse orientation of peptide C. To my knowledge, this is the first time a dissociation 
constant measurement has been made for the just the reverse orientation of a peptide 
when binding to DnaK in a mixed orientation mode.  
  
96 
 
CHAPTER 3 
 
QUO VADIS 
 
3.1 Summary and conclusions 
The central question that has guided my research concerns the manner in which Hsp70 
molecular chaperones interact with and bind their protein clients. For the model Hsp70-
client system detailed herein, I have made several first-in-kind observations. First, I have 
shown that when the ‘core’ DnaK binding motif within a client protein as presented as 
model peptides, they bind DnaK with roughly equal affinity. Next, I have shown that the 
residues flanking the core DnaK binding motif, commonly termed gatekeeper residues, 
reduce the affinity of the site for DnaK when presented as a peptide. Despite this, 
however, the affinity of DnaK for the full-length proPhoA protein is most similar to the 
core peptides. This suggests that some aspect of the binding interaction between DnaK 
and proPhoA serves to modulate the negative effect the flanking residues have on the 
binding interaction.  
 
Two first principle techniques converge on the conclusion only a single DnaK molecule 
may bind a single proPhoA molecule at a time. In addition, both techniques report 
observations consistent with complexes that consistent of multiple proPhoA molecules 
bound to a single DnaK. These complexes were only observed under complex formation 
conditions with molar excess of proPhoA relative to DnaK.  
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The binding data combined with the determination of the DnaK-proPhoA complex 
stoichiometry lead me to develop both the single-site and multiple-site binding models 
for the DnaK-proPhoA system. Chemical shift fingerprinting through methyl-TROSY 
NMR validated the single-site binding model for the DnaK-proPhoA complex. 
Furthermore, my results were consistent with a model in which DnaK is binding solely to 
the D binding site on proPhoA. Mapping the CSPs of DnaK caused by binding each 
peptide back onto those caused by binding proPhoA supported this result. This technique 
was also consistent with the hypothesis that DnaK is binding peptide C in a mixture of 
the forward and reverse orientations. Using the intensities of the peaks in the NMR 
spectrum combined with the binding data allowed me to estimate the dissociation 
constant for peptide C while bound to DnaK in the reverse orientation. 
 
3.2 Significance of the findings 
This is the second in-depth mechanistic study of an Hsp70 molecular chaperone binding 
to a full-length substrate protein. Any conclusions reached based on these data with this 
system would be novel. This is the first time, to my knowledge, that different potential 
DnaK binding sites have been compared and validated within the context of a substrate 
protein. The solvent accessibility of the five DnaK binding sites within unfolded 
proPhoA allows for the possibility of the chaperone binding at each site or selecting for a 
dominant binding site, something that has not been possible in previous work. The 
similar binding affinity for each of the core peptides allows us to speculate on a ‘triage’ 
role for DnaK in its anti-misfolding function. Equal binding affinity suggests that DnaK 
will be only limited by accessibility, or the lack thereof, to a binding site, rather than the 
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affinity for the site itself. In this manner, DnaK is agnostic for whatever binding region is 
exposed; it will aid all of them equally.  
 
In particular, the stoichiometry of the complex being limited to 1:1 in the presence of 
molar excess of DnaK is quite provocative. This conclusion is at odds with published 
models in (Kellner et al., 2014) and speculative cartoons in (Sekhar et al., 2016) as well 
as conventional wisdom in the field. The alternate complex stoichiometries formed in the 
presence of excess proPhoA are provocative and will allow the field to speculate on their 
role and significance well into the future. Perhaps their presence indicates that in the 
absence of the cellular milieu, or under stress conditions of ATP depletion, DnaK takes 
on a ‘default’ role of holdase, preventing aggregation as much as possible.  
 
 Despite the breadth of the work shown here, the very bane of a model system is that at its 
core it is a model. Normally scientists take advantage of this fact to great effect, but it 
always begs the central question: how generalizable is this? According to sequence 
alignments, DnaK is quite similar to various human Hsp70s, but work from this 
laboratory is already casting some doubt on the comparisons (Wenli Meng, personal 
communications).  
 
The Holy Grail of this work would be the first ever structure (or structural ensemble) of 
an Hsp70 bound to a full-length client protein. Structures of chaperones bound to full-
length client proteins have been published for trigger factor (Saio et al., 2014), Hsp90 
(Verba et al., 2016), SecB (Huang et al., 2016), and Spy (Horowitz et al., 2016). Such 
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insights are eminently possible for this system, particularly if experiments such as those 
in (Saio et al., 2014) and (Huang et al., 2016) and employed. Such a structure would be 
an almost infinite value to the field as a general model for Hsp70-substrate interactions 
and bring this work that much closer to being therapeutically relevant. In general, the 
principles and techniques used herein may be generalizable for future work, but any 
therapeutic value will require a disease-implicated Hsp70 and substrate system.  
 
3.3 Future directions 
One of the largest outstanding questions from this work is why does DnaK only appear to 
bind at site D? Occam’s razor states that the simplest conclusion is most often the correct 
one. Extending this principle to my system, one would assume that site D has the highest 
affinity for DnaK, as has been shown in previous work with a different substrate 
(Rodriguez et al., 2008). This has been shown not to be the case, although the possibility 
exists that the correlation between peptide and protein is inadequate with regards to 
affinity. This line of reasoning can be further tested by analyzing the role of the flanking 
vs. core residues in the DnaK binding site in terms of binding site selection. An 
experiment to test the necessity of the core residues in the binding site in regards to 
binding site selection would be to incubate equal concentrations of each core peptide with 
DnaK, then map the peptide CSPs using methyl-TROSY NMR as previously described. 
If peptide D is selected, then the origin of the binding site selectivity is limited to the core 
binding site. If D is not selected, the experiment can be repeated using the extended 
peptide variants. If D is selected when the extended peptides are used, it will implicate 
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either the flanking residues, or perhaps more likely, some complimentary effect between 
the core and flanking residues of the binding site.  
 
In order to disentangle those two possibilities, a binding site swap mutation could be 
performed in context of the full-length proPhoA protein. This experiment would entail 
swapping the D core residues for another site, example for site B, and then determine the 
binding site using previously described methods. This experiment has redundancy with 
the previous two, but if the binding site were to be altered with the ‘swapped’ proPhoA, it 
would also allow finer control of the system and re-introducing the flanking residues via 
point mutations. In this manner, it would be possible to determine which of the flanking 
residues are responsible for, or contribute to, selectivity. An measurement of the 
energetic contribution of each residue to this interaction could be determine through 
judicious use of the competition-based binding assay previously described combined with 
both the mutated proPhoA protein(s) as well as model peptides containing the mutations. 
 
Another potential model for DnaK displaying selective binding at site D is that there is an 
allosteric effect between some distal part of proPhoA and DnaK. The disordered C-
terminus, required for full chaperone activity as seen in (Smock et al., 2011), was the 
most likely candidate for this allosteric site. My work has shown that the dissociation 
constant for DnaK binding proPhoA is not significantly altered when using a DnaK point 
mutant that abolishes C-terminal contacts (D628A). Nevertheless, it remains to be seen if 
the D628A mutant has the same selectivity for site D on proPhoA as wild-type DnaK. 
This could be examined using the methyl-TROSY NMR approach I described earlier in 
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this thesis. Likely the peptide work would not need to be repeated as the C-terminal 
mutants have already shown similarity in binding capacity and ATPase stimulation for 
model peptides as compared to wild-type (Smock et al., 2011). 
 
One of the last models for why DnaK is binding only at site D is that site D is the only 
exposed, or the most exposed binding site. This model is inconsistent with previous 
published data on the unfolded nature of proPhoA in (Saio et al., 2014) and (Huang et al., 
2016), but may need further testing, either through circular dichroism or fluorescence r 
covalent labeling followed by mass spectrometry, if the above models do not yield a 
positive conclusion.  
 
As with anything in science or life, there also exists the possibility of the unknown 
entering into the equation. The physical chemical basis for the selection of site D may be 
due to factors not accounted for in the above models. Site D is the most β-branched site, 
with three such resides in sequence. Does this play a role? If so, why is it not reflected in 
binding site affinity? What is the role of polar, but non-charged, residues within the 
binding site? Do they have any effect on the binding interaction? The observation of the 
single binding site within proPhoA leads to more questions than answers, but fortunately 
scientists optimistically term this as job security. There lies much to still be learned about 
this system and Hsp70-substrate interactions in general and I have no doubt those that 
come after me will reap the rich rewards of such endeavors.  
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Whatever the reason for the observation of DnaK binding to only site D, the question still 
remains: why do no additional DnaK molecules bind proPhoA after D is bound? The 
simplest explanation is that D is the only viable binding site, but this is inconsistent with 
the competition binding data and ATPase rate stimulation. One potential model for this is 
that once DnaK binds the substrate, it alters the conformation in such as way as to 
prevent other chaperones from binding simultaneously. The easiest manner in which to 
think about this is imagining the substrate like a snake that coils itself around DnaK. This 
model is inconsistent with a single stable structure for the bound substrate because the 
binding affinity for the proPhoA protein is of similar magnitude to the core peptides, this 
model would predict that proPhoA would bind much more tightly compared to the 
peptides. Another model is that once Dnak is bound, the free undocked NBD sterically 
hinders the approach of additional DnaK molecules. This model, while consistent with 
the data, is a model of exclusion and as a result, I am somewhat less enthusiastic about it. 
The best manner to directly test this model would be to computationally simulate DnaK 
binding to proPhoA and monitor the dynamics of the NBD, however, this would likely be 
extraordinarily computationally expensive. The presence of a single utilized DnaK 
binding site on proPhoA begs the question: what happens if the preferred binding site on 
a substrate is removed? Does the stoichiometry change? Is the single-site binding model 
or multiple-site binding model valid? Does the affinity change? What site(s) does DnaK 
bind under these circumstances? Mutating site D on proPhoA to remove one or more 
hydrophobic residues and replacing it with negative charge should abolish DnaK binding 
to that site. From there, any number of methods that I, or others, have used can be 
employed to answer any or all of these questions.  
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As tantalizing as the single binding site observation is, I have been more captivated by 
the multiple CSPs that have been observed in the DnaK-proPhoA NMR spectrum that lie 
outside of the diagnostic canonical peptide binding groove residues. These CSPs have 
been assigned for roughly five well resolved resides outside of the diagnostic peaks used 
previously in this thesis. These CSPs are similar in magnitude and direction as those 
observed for the allosterically active state of DnaK (Zhuravleva et al., 2012). This leads 
me to propose a model of whereby DnaK is partially docked when proPhoA is bound. 
This partial docked state would have a dynamic lid, as seen in (Schlecht et al., 2011), that 
is potentially responsible for the, or at least some, observed CSPs. Such as partially 
docked state has been seen for DnaK in the allosterically active state when substrate and 
ATP are bound simultaneously (Zhuravleva et al., 2012) and for the human protein 
HspA1 when ADP is bound (Wenli Meng, personal communication).  
 
At the risk of speculating further, why would binding a protein substrate show this effect? 
It is known that the allosterically active state of DnaK is formed via a tug-of-war between 
ATP and substrate (Zhuravleva et al., 2012). This was elucidated using peptide substrates 
p5 and NR. One model for how the interdomain linker mediates allostery between the 
NBD and SBD of DnaK is through acting as a spring (Charles English, personal 
communication). If this model were taken further, substrate binding stimulates the 
ATPase rate of DnaK, thereby promoting the undocking of the two domains. If the 
substrate were sufficiently massive, however, it may also oppose the undocking motion. 
This behavior would not have been observed with a model peptide of ~1.5 kDa molecular 
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weight. This would lead to a hypothesis whereby the mass of the substrate influences the 
propensity for docking/undocking of the NBD and SBD of DnaK. This could be tested 
using the methyl-TROSY experiments with using either a larger substrate, or a fragment 
of proPhoA and mapping the CSPs. There are potential other reasons and hypotheses for 
why this behavior might be observed, such as allosteric effects, but mass of the substrate 
is the simplest explanation.  
 
Outside of the partial docking model, high quality NMR spectra of DnaK bound to 
proPhoA would yield a treasure trove of potential information about the nature of the 
complex. What is the role of the C-terminus? As there are no ILV residues in the C-
terminus, alanine labeling would need to be employed to address this question. Certain 
relaxation or NOE-based experiments could be used to determine the interactions and 
dynamics of association of the C-terminal tail with the substrate. Is the NBD strictly 
required for the formation of the DnaK-proPhoA complex? Addressing this question 
would likely be a publication in itself, as it would necessitate replication of the work in 
this thesis, using solely the SBD of DnaK as the chaperone. Beyond the question of 
complex formation, does the NBD and associated CSPs, play a role in binding site 
selection? Again, use of the SBD would help answer this question as the diagnostic 
residues used for binding site determination are in the canonical peptide-binding groove 
within the SBD. This approach combined with the segmented labeling approach detailed 
in (Clerico et al., 2010), would provide powerful tools to investigate this system further. 
What portions of the SBD are essential for substrate binding? Some work has already 
been performed in this area, notably (Smock et al., 2011), (Mayer et al., 2000), 
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(Pellecchia et al., 2000), and (Swain et al., 2006). As is often the case in this field, the 
available literature is limited due to the lack of a study using a full-length protein 
construct. An area of interest might be truncating the α-helical lid of the SBD to 
determine the effect on substrate binding or binding site selection in the context of a full-
length substrate protein. The DnaK-proPhoA system represents perhaps a nigh-perfect 
system to interrogate this further.    
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APPENDIX 
 
DERIVATION OF CHENG-PRUSOFF EQUATION AND DATA TABLES 
 
The derivation shown below is taken verbatim from (Cheng and Prusoff, 1973). All 
descriptions following this introduction are taken from the published source (Cheng and 
Prusoff, 1973). Some terms have been renamed due to the fact that the context these 
equations were used in this work was not based on enzymatic activity, but also for clarity.  
 
Terms used in this derivation: 
Vmax = Maximum velocity 
v0 = Velocity in the absence of inhibitor 
KM = Michaelis constant of labeled substrate 
S = Concentration of labeled substrate bound to receptor at K’D 
K’D = Apparent dissociation constant of competitor 
KD = Absolute dissociation constant of competitor 
I = Concentration of competitor 
Bracketed terms indicate the concentration of the term bracketed 
The Michaelis-Menten equation: 
𝑣0 =
𝑉𝑚𝑎𝑥[𝑆]
𝐾𝑀+[𝑆]
      (1) 
Case I. When a competitive inhibitor is present 
𝑣𝐼 =
𝑉𝑚𝑎𝑥[𝑆]
𝐾𝑀(1+
[𝐼]
𝐾𝐷
+[𝑆])
     (2) 
When [I] = K’D, v0 = 2 vI, then 
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2𝑉𝑚𝑎𝑥[𝑆]
𝐾𝑀(1+
𝐾′𝐷
𝐾𝐷
)+[𝑆]
=
𝑉𝑚𝑎𝑥[𝑆]
𝐾𝑀+[𝑆]
  
By rearrangement: 
𝐾′𝐷 = 𝐾𝐷(1 +
[𝑆]
𝐾𝑀
)     (3) 
Equation (3) is the form I have used to analyze the competition-based binding data 
throughout the thesis when referring to the Cheng-Prusoff equation.  
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Chaperonea Peptide         Subsite Binding
c    
        -3 2 1 0 1 2 3+ 
Orientation Origin of 
Peptide 
Ref 
EC DnaK SBDb  NR        N R L L L T G Forward 
Phage 
Display 
(Gragerov 
and 
Gottesman, 
1994) 
EC DnaK SBD NR     N R L L L T G Forward 
Phage 
Display 
(Zahn et 
al., 2013) 
EC DnaK SBD LML    N R L M L T G Forward 
Phage 
Display 
Variant 
(Zahn et 
al., 2013) 
HS HspA1 SBD NR        N R L L L T G Forward 
Phage 
Display 
(Gragerov 
et al., 
1994) 
GK DnaKd Linker        V K D V V L L Forward 
Interdomain 
linker  
(Marcinow
ski et al., 
2011) 
EC DnaK SBD LYZ     K L Y Z  L P R P T P P R Pe Forward 
Antimicrobial 
pyrrhocoricin  
(Zahn et 
al., 2013) 
EC DnaK SBD 1-11_LYZ     K L Y Z L P R P T Forward 
Antimicrobial 
pyrrhocoricin  
(Zahn et 
al., 2013) 
EC DnaK SBD 1-10_LYZZ         L Y Z Z P R P T Forward 
Antimicrobial 
pyrrhocoricin  
(Zahn et 
al., 2013) 
EC DnaK SBD 1-10_LYZI          L Y Z I P R P Forward 
Antimicrobial 
pyrrhocoricin  
(Zahn et 
al., 2013) 
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EC DnaK SBD W/T         G S Y L P R P T P P Forward 
Antimicrobial 
pyrrhocoricin  
(Zahn et 
al., 2013) 
EC DnaK SBD Onc72      K P P Y L P R P R P P Forward 
Antimicrobial 
onconin  
(Zahn et 
al., 2013) 
EC DnaK SBD 1-15      R P P Y L P R P R  Forward 
Antimicrobial 
PR-39  
(Zahn et 
al., 2013) 
EC DnaK SBD 1-20      P R P Y L P R P R P P R P Forward 
Antimicrobial 
designed 
(Zahn et 
al., 2013) 
EC DnaK SBD 3-11       R P V Y I P R P Forward 
Antimicrobial 
apidaecin  
(Zahn et 
al., 2013) 
EC DnaK SBD 4-11           P V Y I P P P Forward 
Antimicrobial 
apidaecin  
(Zahn et 
al., 2013) 
EC DnaK SBD PL          E L P P V K I Reverse 
IscU, EC Fe-
S assembly 
protein  
(Blond-
Elguindi et 
al., 1993) 
EC DnaK SBD PP          E L P L V K I Reverse 
Variant of 
IscU peptide 
(Zahn et 
al., 2013) 
EC DnaK SBD NR             N R L I L T G Reverse 
Phage 
Display 
Variant 
(Zahn et 
al., 2013) 
EC DnaK SBD 3-11              P R P I Y V P Reverse 
Apidaecin 
variant, Api88 
(Fourie et 
al., 1994) 
EC DnaK SBD 12-20           P P R P I Y N Reverse 
Antimicrobial 
pyrrhocoricin  
(Zahn et 
al., 2013) 
EC DnaK SBD 12-19       S H P R P I R V Reverse 
Antimicrobial 
drosocin  
(Zahn et 
al., 2013) 
110 
 
EC DnaK SBD 14-21          P R R P V I M R  Reverse 
Antimicrobial 
heliocin  
(Zahn et 
al., 2013) 
 
aEC denotes Escherichia coli; HS, Homo sapiens; GK, Geobacillus kaustophilus. 
bSBD constructs are from aa393 to aa603, E. coli numbering in all cases. 
cThe residue occupying the central pocket is shown in larger font. Residues in italics were 
outside the binding site and generally had high B factors. 
dConstruct is from aa1 to aa603. 
eZ Denotes cyclohexlyalanine. 
 
Table A.1 Binding modes of structurally characterized peptide/Hsp70 
complexes.   
 
A table of every peptide whose structure has been determine while bound to DnaK 
is shown above. The 0th subsite is marked in red. The adjacent -1, -2, etc. sites are 
vertically aligned. The meaning of superscripts within the table are demarcated 
above 
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Core Peptides 
Substrate Sequence KD (µM) 
A RALALLPLSR 0.7 ± 0.03 
B RAKNIILLSR 0.6 ± 0.1 
C RQKPLLGLSR 2.2 ± 0.1 
C’ (Forward) RQKLLLGLSR 0.3 ± 0.05 
C (Reverse) RQKPLLGLSR ~5.3 
D* RGNTLVIVSR 2.7 ± 0.2 
E RGSQLRIASR 0.5 ± 0.04 
F RDQDHAASR >300 
 
*The affinity for core peptide D was determined through a direct binding assay 
Extended Peptides 
Substrate Sequence KD (µM) 
Extended A RKQSTIALALLPLLFTPRR 0.65 ± 0.05 
Extended B SDKPAKNIILLIGDG 4.2 ± 0.7 
Extended C EANQQKPLLGLFADG 12.8 ± 0.7 
Extended D AKKEGNTLVIVTADH 5.3 ± 0.2 
Extended E QEHTGSQLRIAAYGP 5.5 ± 0.5 
 
  
Table A.2 Dissociation constant values for the core and extended peptides.   
 
The dissociation constant (KD) values for each peptide binding to DnaK are 
shown. Each peptide is color coded with regard to the corresponding figure. The 
black, non-bolded residues shown in the core and extended peptide sequences 
represent solubility tags. The dissociation constant for the reverse orientation of 
core peptide C is estimated based on a weighted average of the relative intensities 
of the corresponding NMR peaks in the methyl-TROSY spectrum. The bolded 
residues in the extended peptide sequences represent the flanking residues that 
were added onto the core binding motif. No accurate dissociation constant value is 
available for peptide F due to the lack of a post-transition baseline in the binding 
curve. The affinity for extended peptide F was not determined because its use as a 
negative control had already been determined from the core variant.  
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Substrate DnaK Mutant KD (µM) 
proPhoA Wild-type 1.13 ± 0.03 
proPhoA D628A 1.84 ± 0.2 
 
  
Table A.3 Dissociation constant values for the proPhoA full-length protein.   
 
The dissociation constant (KD) values for proPhoA binding to DnaK mutants are 
shown. Each mutant is color coded with regard to the corresponding figure.  
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[proPhoA] (µM) RMSD f/f0 Relative % of PC Relative % of YS 
6 0.00326 1.48 91.8 8.2 
12 0.00376 1.4 82.3 15.2 
18 0.00623 1.38 76 24 
 
 
  
Table A.4 Fit parameters for the proPhoA dilution series.   
 
The fit parameters (RMSD and f/f0) for the proPhoA dilution series are shown. 
Also shown are the relative percentages of each peak for each concentration of 
proPhoA. Relative intensities were normalized to remove the effect of the artifacts 
peaks. PC refers to purple circle and YS refers to yellow star.  
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[DnaK] 
(µM) 
RMSD f/f0 Relative % 
of PC 
Relative % 
of OS 
Relative % 
of YS 
13 0.0041 1.34 28.1 67.4 4.5 
26 0.00561 1.42 24.1 72.7 3.2 
37 0.0069 1.38 21.7 70.4 4.4 
 
Table A.5 Fit parameters for the w/t DnaK dilution series.   
 
The fit parameters (RMSD and f/f0) for the w/t DnaK dilution series are shown. Also 
shown are the relative percentages of each peak for each concentration of DnaK. Relative 
intensities were normalized to remove the effect of the artifact peaks. PC refers to purple 
circle, OS refers to orange square, and YS refers to yellow star. 
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ATP-Bound T199A 
[T199A] (µM) RMSD f/f0 Relative % of PC Relative % of YS 
13 0.00371 1.45 90.5 9.45 
26 0.00611 1.4 87 12 
37 0.00652 1.27 78 15.4 
 
ADP-Bound T199A 
[T199A] 
(M) 
RMSD f/f0 Relative % of 
PC 
Relative % of 
OS 
Relative % 
of YS 
13 0.00374 1.28 75.3 20.2 4.4 
26 0.00464 1.29 63.4 27.4 9.1 
37 0.00505 1.28 55.4 29.4 15.1 
 
  
Table A.6 Fit parameters for the ATP- and ADP-bound T199A dilution series.   
 
The fit parameters (RMSD and f/f0) for the ATP- and ADP-bound T199A dilution series 
are shown. Also shown are the relative percentages of each peak for each concentration of 
T199A. Relative intensities were normalized to remove the effect of the artifact peaks. PC 
refers to purple circle, OS refers to orange square, and YS refers to yellow star. 
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Molar ratio 
(DnaK:proPhoA) 
RMSD f/f0 
1:1 0.00654 1.38 
2:1 0.00432 1.36 
3:1 0.00512 1.32 
4:1 0.00777 1.37 
5:1 0.00761 1.37 
 
 
  
Table A.7 Fit parameters for the excess DnaK complex titration.   
 
The fit parameters (RMSD and f/f0) for the DnaK complex titration are shown.  
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Molar ratio 
(DnaK:proPhoA) 
RMSD f/f0 
1:2 0.00426 1.27 
1:3 0.00545 1.2 
1:4 0.00691 1.18 
 
 
  
Table A.8 Fit parameters for the excess proPhoA complex titration.   
 
The fit parameters (RMSD and f/f0) for the proPhoA complex titration are shown.  
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